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Abstract
Over the course of this study, various species of Tongan marine sponges were investigated
using an NMR-based screening method and has resulted in the discovery of three new
sesterterpenes and 11 known compounds.
Examination of the sponge Fascaplysinopsis sp. resulted in the isolation of two novel
sesterterpenes, isoluffariellolide (46) and 1-O-methylisoluffariellolide (47). Compounds
46 and 47 share the same backbone pattern as the known luffariellolide (45) and 25-O-
methylluffariellolide (107) respectively, and differ only in the substitution pattern of the
butenolide rings. Isoluffariellolide (46) was found to be approximately six times less
cytotoxic than 1-O-methylisoluffariellolide (47). Interestingly, these results suggested
that the 1-O-methyl group in compound 47 plays an important role in the cytotoxicity of
the compound.
Secothorectolide (49), a new ring-opened and geometric isomer of the known compound
thorectolide (48), was obtained from a sponge of the order Dictyoceratida. This
ring closure and opening relationship was also observed between manoalide (109) and
secomanoalide (110), as well as luffariellins A (141) and B (142). Despite the different
carbon skeleton, the functional groups in 141 and 142 are similar with those in 109 and
110, respectively, and not surprisingly the biological properties are almost identical. The
biological activities of compounds 48 and 49 were almost the same, which would give an
insight into the structure-activity relationship (SAR) between these types of compounds.
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Chapter 1
Introduction
1.1 The Role of Natural Products in Medicine
Historically, humankind has constantly relied on Nature to improve various aspects of our
life. Nature has provided our basic needs for survival such as sources of food, shelter,
textiles, cosmetics and medicines.1 Terrestrial plants have been the basis for traditional
medicines and herbal remedies for centuries and have been widely documented in many
cultures. Records as early as 2600 BC from Mesopotamia on the use of plant materials
in medicine were written on hundreds of clay tablets in cuneiform.1 In ancient Egypt,
medicines were used as early as 2900 BC, and the “Eber Papyrus” (written in about 1500
BC) is the best known medical text from this era, documenting over 700 (mostly plant-
based) medicines.2 The Chinese “Materia Medica”, has been repeatedly documented over
centuries (∼1100 BC) along with the “Shennong Herbal” (∼100 BC) and the “Tang
Herbal” (659 AD), documented the uses of thousands of plants as drugs or medicines.2
The Indian Ayurveda (1000 BC) described in detail the uses of over 1000 different drugs
or remedies.1,2 In the Western World, Greeks and Romans contributed to the development
of the use of herbal medicines from around 300 BC, but it was the Arabs that were
responsible for maintaining and expanding this knowledge.1–3
The therapeutic effect of these traditional medicines is generally due to biologically
active secondary metabolites present within the plant material. However, the study of
secondary metabolites (also known as natural products) from terrestrial plants only began
in the 1800s, where scientists isolated, purified, and defined these active substances.
Subsequently, countless numbers of biologically active compounds have been isolated
from terrestrial sources, many of which are used as modern-day drugs for treating various
diseases and other medicinal purposes. For example, ancient texts from Mesopototamia
indicated the use of poppy juice from the opium poppy (Papaver somniferum) for
therapeutic means. But it was not until 1806 when the active compound, the narcotic
1
analgesic morphine (1), was isolated by Serturner.4 Morphine is considered as the first
bioactive compound isolated from Nature and the first commercialised pure natural
product used for medical purposes.4 Moreover, the “Eber Papyrus” mentioned the use of
willow leaves as an antipyretic treatment. The Greeks and the Romans also discovered the
antipyretic and analgesic properties of willow bark around 400 BC. In the mid 1800s, the
bioactive compound salicin (2), was discovered, although it was its derivatives, salicylic
acid (3) and aspirin (acetylsalicylic acid, 4) that were commercialised in 1899.4 Aspirin
(4) was the first semi-synthetic drug based on a natural product, and features as the most
successful and widely used medication worldwide.3,4
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1.2 The Onset of the “Golden Era of Antibiotics”
The serendipitous discovery of penicillin G (5) from the fungus Penicillium notatum
in 1929 heralded the modern era of antibiotics.1,2 This discovery signaled what many
then believed to be the end of infectious disease. Followed by the success of large-
scale production of penicillin during the World War II, pharmaceutical companies
and scientists all over the world shifted their focus to the newly discovered world of
microbes.5 From the 1940s to the 1970s, microbes were found to be prolific sources
of structurally diverse, biologically active metabolites. This led to the discovery of
new antibiotics ranging from antibacterial agents such as penicillins, aminoglycosides
(e.g. streptomycin, 6), antiparasitic drugs (e.g. ivermectins) to immunosuppressive
agents such as rapamycin (also known as sirolimus, 7).1,2,5 This large collection of
bioactive metabolites served as the modern foundation for the treatment of infectious
disease, and along with the introduction of better hygiene standards, led to a dramatic
reduction in worldwide morbidity and mortality due to bacterial infections.6 About one-
half of the drugs commonly used today were discovered during this era, referred to
2
as the “Golden Age of Antibiotics”.6 Unfortunately, this period has been short-lived,
due to the resurgence of disease-causing pathogens and parasites that have developed
resistance to these chemotherapies.7 Today, natural product chemists and pharmacologists
are increasingly turning to new sources in the search for biologically active compounds,
especially the marine realm.7
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1.3 Marine Natural Products
The marine environment covers more than 70% of our planet’s surface and life on Earth
has its origin in the sea.8 This environment contains 34 of the 36 known phyla of life
and offers a greater biodiversity than that of the terrestrial environment.9 Secondary
metabolites isolated from the marine environment often have unusual and complex
structures with unique functionalities and possess pronounced biologically activity. This
is due partially to the harsh and extreme environments in which the marine organisms
may inhabit, such as high salinity, extreme pressure, low light intensity, variable
temperature and low nutrient availability. Because environmental conditions in the
3
marine environment are so noticeably distinct, the chemistry produced by its inhabitants
is also quite varied. As the terrestrial sources of pharmaceuticals and biochemicals
have been considerably explored, less than 1% percent of marine species have been
examined for novel chemistry.10–13 Thus, the oceans represent a rich and still largely
untapped resource for biologically active compounds. In addition, completely unknown
biochemical pathways in pathogens or disease may be discovered and targeted by such
unique chemotypes, leading to the development of novel therapeutics.
Marine natural products were largely unexplored because of the difficulties involved in
collecting samples. The development of technologies such as SCUBA in the 1950s, and
more recently submersible vehicles, has allowed underwater exploration in both shallow-
and deep-water more achievable. The first therapeutic agents from marine environment
were reported in the 1950s by Bergmann et al. through their discovery and isolation
of two novel biologically active nucleosides, spongouridine (8) and spongothymidine
(9), from a Caribbean marine sponge Crypotethia crypta.14–16 Subsequent development
of synthetic analogues has provided clinically relevant agents, including the anti-HIV
drug azidothymidine (AZT, 10), the antiviral agent vidarabine (Ara-A, 11) and the
arabinosyl cytosine (Ara-C, 12). Compound 12 in particular is the first marine-derived
anti-cancer agent, used for the treatment of acute myelocytic leukemia and non-Hodgkin’s
lymphoma.17 The discovery and development of compounds 8 and 9 created interest in
the marine derived secondary metabolites and is considered to be the first significant
discovery of biologically active compounds from the marine environment. Since then,
through combined efforts, marine natural product chemists and pharmacologists have
isolated an impressive number of promising compounds that are either already at
advanced stages of clinical trials (mostly in the treatment of cancer), or have been selected
as promising candidates for extended preclinical evaluation.18 The majority of these
compounds are produced by invertebrates such as sponges, tunicates, soft corals, sea
squirts, molluscs or bryozoans.
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1.4 Marine Sponges
Marine sponges, or poriferans (from Latin porus “pore”, and ferre “to bear”), belong
to phylum Porifera, and are considered to be the most primitive group of multicellular
animals because they do not have true organs or tissues.19 For this reason, sponges were
excluded from the animal kingdom until the late 1800s.19 Sponges are ubiquitous benthic
creatures, found at all latitudes beneath the world’s oceans, from intertidal zones to the
deep sea. Molecular genetics evidence placed the divergence of sponges to around 800
million years ago,20 suggesting that sponges were widespread inhabitants of the reefs
and their simplistic nature was a highly successful and persistent one.19 At this time,
about 15,000 extant species have been described, and there are possibly twice as many
undescribed species.21
Sponges are simple multicellular invertebrates that filter large quantities of seawater
and acquire nutrients by phagocytosis of captured bacteria.22 They are sessile, soft-
bodied, and are prone to predation and other environmental stress factors. Sponges have
experienced an intense evolutionary pressure to evolve and produce biologically active
and antagonistic metabolites. These compounds are rapidly diluted after being released
into the water and hence have to be of outstanding potency to retain their efficacy.8 These
secondary metabolites serve as a chemical defense mechanism which compensates for
their lack of morphological defense structure, such as spines or a protective shell. This
is no coincidence but it reflects the ecological importance of these constituents for the
marine sponge. A great diversity of highly toxic compounds or distasteful metabolites is
an effective strategy to fight off potential predators or to force back neighbours competing
for space.18 These metabolites affect numerous biological targets which make these
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organisms of great interest to marine natural products chemists and pharmacologists.
Most of the known species of sponges feed on bacteria and some host photosynthesising
micro-organisms in an endosymbiotic relationship.22 Some sponges have been shown to
harbour a large number of bacteria, in some cases up to 60% of the tissue volume.23
The sponges provide the micro-organisms with a protected environment for growth and
reproduction, and the sponges obtain oxygen and nutrients from the micro-organisms.
Due to this relationship, there is an uncertainty as whether the biologically active
metabolites isolated from sponges are in fact produced by the sponges or the micro-
organisms. Recent studies have shown that a number of secondary metabolites can be
attributed to the symbiotic micro-organisms.24,25
Sponges display an incredible variety of colours and shapes. In general, sponge
species are difficult to identify by casual comparison to some illustration or photograph.
Sponges have indeterminate growth patterns, such as shape, size, colour and showed
considerable plasticity in response to environmental factors and location. The lack of
structural features make them hard to characterise, which leads to problems with their
classification. However, most sponges have spicules; microscopic skeletal structures that
provide support and sometimes deter predators. Comparison of the shapes and sizes of
these spicules found in the sponge with data from the literature aid the identification
of sponge species (since spicules are the only consistent structures in sponges). From
these characterisations, the Porifera have been divided into three classes: Hexactinellida
(siliceous/glass spicules), Calcarea (spicules of crystalline CaCO3) and Demospongiae
(siliceous spicules and/or collagen fibres).21 The largest class, Demospongiae contains
about 90% of the sponge species within 15 orders and 25 families. The Calcarea is divided
into 24 families within five orders, and the class Hexactinellida contains five orders and
17 families (Table 1.1).21 Recently, different techniques have also been used as tools in
sponge taxonomic classification such as chemotaxanomic trends and molecular biology,
leading to the re-examination of sponge taxonomy at the order level and below.26
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Table 1.1. Taxonomic Classification to Order Level of Phylum Porifera.21
Kingdom Phylum Class Sub-class Order
Metazoa Porifera
Demospongiae
Ceractinomorpha
Agelasida
Dendroceratida
Dictyoceratida
Halichondrida
Halisarcida
Haplosclerida
Poecilosclerida
Verongida
Verticillitida
Tetractinomorpha
Astrophorida
Chondrosida
Hadromerida
“Lithistids”
Spirophorida
Homoscleromorpha Homosclerophida
Hexactinellida Hexasterophora
Aulocalycoida
Hexaactinosida
Lychnicosida
Lyssacinosida
Amphodiscophora Amphodiscosida
Calcarea
Calcaronea
Lithonida
Leucosolenida
Baerida
Calcinea ClathrinidaMurrayonida
1.5 Tongan Marine Sponges and Chemistry
Secondary metabolites isolated from tropical marine sponges are noted for their novelty
and high chemical diversity, exhibiting a broad range of biological activities and unusual
structures. The intense tropical coral reefs and warm waters comprise some of the densest
and most diverse habitats for enormous numbers of organisms. As a result, the tropical
sponges tend to use less energy through homeostasis due to the warmer waters in which
they live, therefore they are able to devote more energy to producing biologically active
compounds as chemical defenses. Additionally, the higher grazing pressure from many
different predators enhanced the production of biologically active compounds.
The Kingdom of Tonga is an archipelago in the Central Indo-Pacific Ocean consisting
of 176 islands (36 of which are inhabited). Tonga is located at latitude 20o 0′ 0′ ′ S and
longitude 175o 0′ 0′ ′ W (Figure 1.1) and is divided into four main groups; Tongatapu,
Vava‘u, Ha‘apai and ‘Eua. The largest island, Tongatapu, on which the capital of
7
Figure 1.1. Map of the Kingdom of Tonga. Map courtesy of LINZ.
Nuku‘alofa is located covers 257 square kilometres. Geologically the Tongan islands are
of two types: most have a limestone base formed from uplifted coral formations; others
8
consist of limestone overlaying a volcanic base. Due in part to its geographical central
location at the meeting of two oceans (Indian and Pacific Oceans), Tongan waters have a
distinct marine realm and comprise one of the greatest diversity of marine life. Tonga has
a total land area of 688 sq km with Exclusive Economic Zone (EEZ) of 700,000 sq km,
1000 times more its land area, thus Tonga is an excellent place to study marine natural
products.
There are few reports of marine natural products isolated from Tongan marine organisms,
even though its marine environment offers an amazing and fascinating biodiversity. The
first marine natural products research group to investigate the Tongan sponges was led
by Phillip Crews from the University of California at Santa Cruz. Their collections were
made in the early 1980s from Vava‘u and the Ha‘apai groups, located in northern Tonga.
The first novel compound reported from the Tongan marine environment was nuapapuin
A methyl ester (13) (formerly known as methyl nuapauanoate) isolated together with
the known norsesterterpene muqubilin (14).27,28 Compound 13 was obtained from a
large soft drab sponge initially identified as Prianos sp., but revised to Diacarnus
cf. spinopoculum, and is considered to be the first norditerpene isolated from a
marine sponge.28,29 Nuapapuin A (13) demonstrated selective cytotoxicity against eight
tumour cell lines in the soft agar assay, with GI50 values of less than 0.5 µM.28
Interestly, the norditerpene peroxides clearly demonstrated superior profiles compared
to the norsesterterpene peroxides.28 A study of the anti-flammatory active extracts from
the sponge Hyrtios erecta revealed a novel scalarane norsesterterpenoid, hytrial (15).30
Hytrial (15) was re-isolated with a further five novel scalarane-type sesterterpenes (16–
20).31 Compound 15 has shown to decrease by 43% the weight of mouse ear oedema
induced by PMA at a concentration of ca. 50 µg per ear.31 Heteronemin acetate (17) was
also cytotoxic against the human normal cell line (human oral fibroblasts) with an IC50
value of 16.09 µM.32 12-Deacetyl-12-epi-scalaradial (16) and 17 showed antitubercular
activity with MIC values of 63 µM and 3 µM respectively.32 It was suggested that the
oxygenated pattern at C-24 and C-25 of the scalarane-type sesterterpenes might assert a
strong influence on their resultant biological activities.31
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Psammaplin A (21) was reported in 1987 from the marine sponge Psammaplysilla sp.,
and is the first example of a disulfide derived from a marine sponge.33 In 2007, 20 years
after the first report, there were 45 articles published based on the chemical study of
21.34 Compound 21 inhibits the activities of several key enzymes in prokaryotic and
eukaryotic systems, including those involved in epigenetic control of gene expression,
DNA replication, angiogenesis, microbial detoxification, and tumor cell growth.35–44
Three novel isomalabaricane triterpenes (22–24) were obtained from the organic extract
of the specimen of Japsis sp. collected near Tonga, along with known triterpene 3-epi-
29-hydroxystelliferin E (25).45 As isomalabaricane triterpenes are known to isomerise
upon exposure to light, the isomeric mixtures of the four compounds were tested against
melanoma (MALME-3M) and leukemia (MOLT-4) cell lines. Against MALME-3M
cell line the mixtures of 29-hydroxystelliferin A (23)/29-hydroxystelliferin B (26) and
stelliferin G (24)/13E-stelliferin G (27) were the most growth-inhibitory (IC50 values of
0.11 and 0.23, µg/mL respectively).45 The other two mixtures, 29-hydroxystelliferin E
(22)/13E-29-hydroxystelliferin E (28) and 3-epi-29-hydroxystelliferin E (25)/13E-3-epi-
29-hydroxystelliferin E (29), were approximately 10-fold less potent with a similar trend
observed with the MOLT-4 results.
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The paucity of investigation and analysis on Tongan marine fauna and the promising
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results mentioned above suggested that more research should be carried out on Tongan
marine organisms. To date, there are no reported marine natural products isolated
from Tongan marine organisms other than sponges. For the last two years, the Marine
Natural Products group at Victoria University of Wellington (VUW) has shifted their
research and attention from New Zealand marine organisms to the tropical Pacific
marine environment of Tonga. Recent results include the re-isolation of zampanolide
(30), a potent 20-membered macrolide from the Tongan marine sponge Cacospongia
mycofijiensis.46 Although compound 30 was originally reported from the Japanese marine
sponge Fasciospongia rimosa, and exhibited potent cytotoxicity against several cell lines
(IC50 1–5 ng/mL), there was no information available on the mode of action.47 The recent
isolation of 30 allowed further investigation on its mode of action, which proved to
be a novel and potent microtubule-stablising compound. This places zampanolide (30)
in an important group of anti-cancer compounds that includes the clinically valuable
paclitaxel (31), docetaxel (32), ixabepilone (azaepothilone B, 33); and a number of
other potent microtubule-stabilising agents, including laulimalide (34), peloruside A
(35), discodermolide (36), and dictyostatin (37).48,49 Zampanolide (30) is cytotoxic
in nanomolar concentrations by arresting cells in the G2M phase of the cell cycle
by polymerising microtubules.46,50 Further examination of C. mycofijiensis generated a
number of known bioactive compounds, including laulimalide (34) and isolaulimalide
(38) (both are microtubule-stabilising agents), latrunculin A (an actin-destabilising agent,
39), dendrolasin (having pheromonal activity, 40), and mycothiazole (41).50
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Chapter 2
Isolation and Screening of Secondary Metabolites
2.1 Isolation Techniques
The goal of the Marine Natural Products Group at VUW is to isolate novel chemical
structures with interesting and useful biological activities, utilising novel techniques.
These include a chromatographic method, cyclic loading, as well as NMR-based
screening methods, which are discussed below.
2.1.1 Cyclic Loading
For biological activity of secondary metabolites to be effective, the structure must possess
a mixture of both hydrophilic and hydrophobic properties that enables them to be easily
transported across cell membranes and other biological barriers.51 The crude extracts of
sponges contain a wide range of compounds with varying degrees of polarity, ranging
from polar amino acids, salts and sugars to non-polar fats, lipids and steroids. This can be
best described in terms of a “mass window” (Figure 2.1), where the intermediate region
(lowest relative mass, mid-polarity) contains few primary metabolites, making the mass
window an ideal target for the first stage of fractionation of a crude extract.
The Marine Natural Products group at VUW has developed a technique known as
“cyclic loading”.52 This reversed-phase chromatographic technique utilises poly(styrene-
divinylbenzene) (PSDVB), as the stationary phase. The resin is an inexpensive, chem-
ically inert, crosslinked polymeric resin, that is highly porous, lacks polar sites, and is
stable over a large pH range.53 These characteristics contribute to the repeated use of
PSDVB without any significant decrease in performance. The first stage of cyclic loading
involves passing the extract(s) through the column. This allows most of the non-polar
compounds in the extracts to adhere to the PSDVB beads. The eluent is then diluted
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with H2O and passed back through the column. Under the normal circumtances, addition
of H2O to a crude extract would result in the precipitation of the non-polar compounds,
which is avoided during cyclic loading, as the most non-polar fats and triglycerides have
adsorbed to the column during the first pass. As the eluent is gradually made more polar
by each dilution with H2O, the more polar compounds in the extract are adsorbed to the
column. The cyclic process is repeated until all the compounds of interest are adhered to
the PSDVB beads in the column.
200 40 60 80 100
% organic modifier in H2O
high polarity mid-polarity low polarity
(salts/carbohydrates) (target metabolites) (lipids/steroids)
mass window
1
relative
concentration
Figure 2.1. Schematic of the mass distribution in a typical marine sponge extract.
Once the crude sponge extracts are retained in the column, it is washed with distilled H2O
to remove any remaining salts. The loaded column then can be sequentially eluted with
a gradient of increasing organic modifier (Me2CO or MeOH)/H2O to obtain a number of
fractions of decreasing polarity. During the elution process, the earlier fractions usually
contain mostly highly polar materials such as amino acids and sugars. The non-polar
materials such as lipids and steroids usually come off in the later fractions. The mid-
polarity materials that contain most of the interesting secondary metabolites are eluted in
the middle fractions (with few exceptions). The fractions obtained from cyclic loading
contain varying amounts of H2O, which is a major problem if the fraction must be
concentrated under vacuum or reduced pressure. This problem is overcome by using a
modified cyclic loading method called “back loading”. The fractions containing water are
further diluted with H2O and cyclic loaded back through the column. The column is then
eluted with pure organic solvent (Me2CO or MeOH), creating a fraction with almost no
water that can be concentrated under reduced pressure more easily.
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Figure 2.2. Schematic of the cyclic loading process.
2.2 Screening of Marine Organisms
2.2.1 Bioassay-Directed Screening
Bioassay (biological assay) directed isolation is the most common technique used for
identifying novel and biologically active secondary metabolites from crude extracts. The
main goal of a bioassay is to find and identify a biologically active compound. Extracts
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with any biological activity are iteratively fractionated and subjected to the same assay
until the pure compound(s) is isolated. The major advantage of this method is the isolation
of a pharmaceutically active secondary metabolite and maybe novel activity against the
chosen target. However, the large number of fractions to be assayed is time consuming
and often costly. Additionally, the activity of lower concentration metabolites can be
masked by a higher concentration metabolite since an organism can produce numerous
biologically active compounds.
2.2.2 NMR-Based Screening
In the case of NMR-based screening, the main goal is to find and isolate novel
secondary metabolites and then investigate their biologically activity after isolation.
Secondary metabolites have a biological function and therefore they may have medical
and pharmaceutical application. This spectroscopy-directed isolation technique employs
NMR spectroscopy as a guide for the isolation and identifies the interesting compounds.
The advantages of this technique is that it is applicable to the isolation of most secondary
metabolites. It has a good response factor and potential for vast structural information
content. However, a solubility issue is a major problem due to larger range of polarities
present in the crude extracts. This problem is overcome by using cyclic loading as the
primary partition stage after extraction.
2.3 VUW Screening Methodology
The VUW Marine Natural Products Group has developed a NMR-based screening
protocol for screening marine sponges and guiding the isolation procedure. Generally,
for screening a typical New Zealand sponge, about 100 g of sponge is extracted twice
with MeOH. For a Tongan sponge, approximately 25 g is required due to the fact that
tropical sponges are richer in chemical contents (smaller amount of sponges are collected
as well). The extracts are then cyclic loaded onto a PSDVB column and then the column
is desalted with distilled H2O. The loaded column is then sequentially eluted with 30%,
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75% Me2CO/H2O and 100% Me2CO. The biologically active secondary metabolites tend
to elute in the intermediate region, the 75% Me2CO/H2O fraction.
The idea behind the NMR-based screening protocol is to analyse the 75% Me2CO/H2O
fraction by differentiating between common and unusual resonances present in the NMR
spectra of semi-purified extracts. This simple screening technique resulted in the isolation
of biologically active compounds such as peloruside A (35) and B (42), among others.52,53
However, the presence of primary metabolites conceals a large portion of the 1H NMR
spectrum, limiting the amount of structural information available. As a result, 2D NMR
experiments (COSY, HSQC, and HMBC) have been used as a screening tool, since 2D
NMR spectroscopy offers more detailed structural information, and a great advantage in
the detection of novel secondary metabolites.
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2.3.1 HSQC Mask
Initially, the COSY experiment was used as a screening tool, but it was deemed
too complicated to be readily converted to a database form, so HSQC spectra with
their relatively simple 1H–13C correlation data were chosen.54 In addition, the HSQC
experiment provided more functional information in the carbon dimension. To construct
the electronic mask, the HSQC data of the 75% Me2CO/H2O screen fractions are added
together to generate a digital mask. For any given screen, the HSQC spectrum is compared
to the mask where common signals (green peaks) are distinguished from those that
are interesting. Correlations that are frequently observed are from compounds that are
common amongst the screened sponges and are therefore likely to be primary or known
metabolite(s). Thus, uncommon correlations (red peaks) may indicate the presence of
novel secondary metabolite(s). The intensity of a particular correlation also indicates the
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relative amount of the compound present in the sponge. This current screen has been used
in the isolation of new secondary metabolites from sponges and also adapted for red algae
screening.54–57 Unfornately, this screening method is based only on New Zealand marine
organisms and has not been applied to Tongan specimens, which is a major problem
during the course of this study, which led to isolation of compounds already known from
the literature.
(a) (b)
Figure 2.3. (a) Computer generated mask of HSQC data (contains 160 sponges). (b)
Common correlations in the HSQC masks.
(a) (b)
Figure 2.4. (a) An uninteresting sponge screen. (b) An interesting screen.
2.4 Future Screening Methods
The HSQC screen has been successful in reducing the volume of extraneous information
which is presented to the analyst by masking out correlations in HSQC spectra which are
of little or no interest due to their repeated occurrence in extracts. At the same time, this
computer-based NMR screen has its limitations. Firstly, the non-protonated functional
groups are not taken into account; for example carbonyl carbons (except aldehydes),
non-protonated olefinic carbons, nitriles, imines, and sp3 quaternary carbons. Secondly,
the selection of the 1JCH value dictates which correlations appear most intense. Since
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1JCH ranges from about 110 to 320 Hz, the current HSQC screen has a optimum 1JCH
value of 140 Hz, which allows 1JCH values between 110-170 Hz to appear with the
highest intensity. Therefore, functional groups with 1JCH values outside this range appear
proportionally weaker or missing unless the optimum value is changed.
2.4.1 HMBC Screen
An additonal screen based on the HMBC experiment is currently being developed in a
similar manner to the HSQC screen. As the HSQC experiment correlates 13C nuclei
with directly attached 1H only, the HMBC experiment offers multiple-bond correlations
between 1H and 13C nuclei (1H–15N HMBC is also utilised) thus providing more
information, especially in the carbon dimension. The experiment can be performed
concurrently with the HSQC screen experiment (mentioned before) and thus interesting
one-bond correlations in the HSQC screen can be extended to multiple-bond correlations
from the HMBC screen. An HMBC screen would potentially be an extremely powerful
technique at an early stage of purification and this would help decide if a sponge extract
is worthy of further investigation without fully committing to the purification process.
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Chapter 3
Sponges Investigated by Spectroscopic Screening
During the course of this study, two collection trips were made to Tonga. The first
collection trip was to Tongatapu and ’Eua in late 2008 and the second was to the Vava‘u
Group in late 2009 (Figure 1.1). A total of 17 marine sponges were screened using the
VUW method. Several sponges were selected for investigation based on their promising
results in the 2D NMR spectra screening method, which led to isolation of novel and
known compounds which are detailed in the following chapters.
3.1 Sponges Screened from Tongatapu and ‘Eua
PTN3 13A
PTN3 13A is a very soft, unidentified orange coloured sponge (940 g) collected by
snorkel from the Popua shoreline, near the capital Nuku‘alofa, Tongatapu, Tonga. The
sponge (22 g) was screened and the screen spectra contained resonances attributed to
aromatics and evidence of peptides observed in HMBC spectrum. A second, large-scale
bulk extraction of the sponge (329 g) was performed. Subsequent analysis of this extract
showed no evidence of the interesting resonances and solubility issues with the NMR
solvents were encountered. No further analysis was performed.
Figure 3.1. Surface photo of the PTN3 13A sponge.
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PTN3 13C
PTN3 13C is an unidentified sponge (833 g) collected from the front coast of Popua near
the capital Nuku‘alofa, Tongatapu, Tonga. 23 g of the sponge was screened. The screen
spectra of the 75% Me2CO/H2O fraction contained non-interesting resonances. Further
purification and analysis was automatically discontinued.
Figure 3.2. Surface photo of the PTN3 13C sponge.
PTN3 14B
PTN3 14B is ann unidentified yellow coloured, finger sponge (130 g) from ‘Ohonua
Harbour, ‘Eua, Tonga. The screen spectra of the 75% Me2CO/H2O fraction contained a
number of resonances largely attributed to aromatics. No further analysis was performed.
Figure 3.3. Surface photo of the PTN3 14B sponge.
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PTN3 14E
PTN3 14E is an unidentified sponge (104 g) collected from ‘Ohonua Harbour, ‘Eua,
Tonga. With 22 g of the sponge being screened, the screen spectra contained resonances
attributed to aromatics, oxymethylene and oxymethine regions. Due to encountering
solubility issues with the NMR solvents, no further analysis was performed.
Figure 3.4. Surface photo of the PTN3 14E sponge.
PTN3 14F
PTN3 14F is an unidentified sponge (274 g) collected from ‘Ohonua Harbour, ‘Eua,
Tonga. 24 g of the sponge was screened and the screen spectra contained resonances
largely attributed to terpenoids with great similarity to that of PTN3 19A and PTN3 22B.
Therefore, further purification and analysis was discontinued.
Figure 3.5. Surface photo of the PTN3 14F sponge.
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PTN3 15C
PTN3 15C is a leathery grey unidentified sponge (525 g) collected from the coastline
of Houma, ‘Eua, Tonga. A 23 g of the sponge was screened. The screen spectra of
the 75% Me2CO/H2O fraction contained resonances attributed to aromatics, olefinic and
oxymethine regions. Further purification and analysis was discontinued.
Figure 3.6. Surface photo of the PTN3 15C sponge.
PTN3 16F
PTN3 16F is an unidentified yellowed coloured, rubble-like sponge (150 g) from the
coastline of Houma, ‘Eua, Tonga. 23 g of the sponge was screened and the screen
spectra of the 75% Me2CO/H2O fraction contained resonances largely attributed to
oxymethine, oxymethylene, and oxymethyl regions with few in the aromatic region.
Further purification and analysis was discontinued.
Figure 3.7. Surface photo of the PTN3 16F sponge.
24
PTN3 18C
PTN3 18C is an unidentified grey dictyoceratid sponge (21 g) collected from the coast of
Houma, ‘Eua, Tonga. The screen spectra of the 75% Me2CO/H2O contained resonances
attributed to aromatics, oxymethyls and oxymethines. No further analysis was perfomed.
Figure 3.8. Surface photo of the PTN3 18C sponge.
PTN3 19A and PTN3 22B
PTN3 19A and PTN3 22B were an unidentified sponges (250 g), reddish-coloured of
the genus Fascaplysinopsis were collected from an underwater cave in southwestern
‘Eua, Tonga, with only 25 g of the sponges screened. The screen spectra of the 75%
Me2CO/H2O fraction contained resonances largely attributed to aromatics and terpenoids.
A second, large-scale bulk extraction of the sponge (200 g) was performed. Purification
and analysis of the bulk extracts led to isolation of the three known compounds
homofascaplysin A (43), isodehydroluffariellolide (44) and luffariellolide (45), along
with two novel sestertepenes, isoluffariellolide (46) and 1-O-methylisoluffariellolide (47).
Isolation and the structure elucidation of the two novel sesterterpenes (46–47) will be
discussed in Chapter 5.
PTN3 21C
PTN3 21C is an unidentified sponge (350 g) from the order Dictyoceratida collected
from an underwater cave in southwestern ‘Eua, Tonga. Only 26 g of the sponge was
originally screened. The screen spectra of the 75% Me2CO/H2O fraction contained
resonances largely attributed to terpenoids and sign of aldehydes. Further purification
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led to the isolation of the known sesterterpene thorectolide (48) and a novel sesterterpene,
secothorectolide (49). The isolation and structural elucidation of secothorectolide (49) is
dealt with in Chapter 6.
PTN3 25E
PTN3 25E is an unidentified orange coloured sponge (400 g) collected from Fa¯fa¯ Island,
located off the coast of Nuku‘alofa, Tongatapu, Tonga. The sponge (22 g) was screened
and the screen spectra contained resonances attributed to aromatics and evidence of
peptides observed in the HMBC spectrum. It was concluded that it is the same sponge as
PTN3 13A. No further analysis was performed.
Figure 3.9. Surface photo of the PTN3 25E sponge.
PTN3 25F
PTN3 25F is an unidentified sponge (700 g) collected from Fa¯fa¯ Island, located off the
coast of Nuku‘alofa, Tongatapu, Tonga. Only 23 g of the sponge was taken for screening.
The screen spectra of the 75% Me2CO/H2O fraction contained resonances attributed to
aromatics and oxymethylene regions. Further purification and anaysis was discontinued.
3.2 Sponges Screened from the Vava‘u Group
PTN3 33F
PTN3 33F is an unidentified sponge (1989 g) belong to the order Verongida was collected
from Ano Beach, Vava‘u, Tonga by snorkel. 27 g was screened and the screen spectra of
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Figure 3.10. Surface photo of the PTN3 25F sponge.
the 75% Me2CO/H2O fraction contained resonances attributed to aromatics, oxymethine
and oxymethyl regions. Further purification of this fraction led to the isolation of two
known bromotyrosine alkaloid compounds aplysamine-2 (50) and aerophobin-1 (51). The
isolation of compounds (50–51) will be discussed in Chapter 4.
PTN3 45H
PTN3 45H is a bright yellow calcareous sponge (825 g) of the genus Leucetta collected
from an underwater cave from Tu‘ungasika Island, Vava‘u, Tonga. 21 g was taken for
screening. The screen spectra of the 75% Me2CO/H2O fraction contained interesting
resonances largely attributed to aromatics. Subsequent purification and analysis of the
75% Me2CO/H2O was discontinued and set aside due to the small sample and lack of
time for large-scale extracts.
Figure 3.11. Underwater photo of the Leucetta sp. (courtesy of Karen Stone).
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PTN3 46E
PTN3 46E is an unidentified sponge (365 g) of the order Verongida, collected from
Tu‘ungasika Island, Vava‘u, Tonga. The sponge (27 g) was extracted and the screen
spectra of the 75% Me2CO/H2O contained resonances attributed to aromatics, oxyme-
thine, oxymethylene, and oxymethyl regions. Further purification of this fraction led to
isolation of three known bromotyrosine compounds fistularin-3 (52), aeroplysinin-1 (53)
and LL-PAA216 (54), which will be discussed in Chapter 4.
PTN4 05D
PTN4 05D is an unidentified sponge (701 g) collected near Hunga, Vava‘u, Tonga. The
sponge (27 g) was selected for screening due to its similarity to genus Fascaplysinopsis
(PTN3 19A collected from ‘Eua). However, the screen spectra of the 75% Me2CO/H2O
fraction contained resonances attributed to terpenoids and nothing in the aromatic regions
(similar to PTN3 14F). Further purification and analysis was discontinued.
Figure 3.12. Surface photo of the PTN4 05D.
PTN4 10A
PTN4 10A is an unidentified black sponge (1449 g) collected from Fakafotula¯, Vava‘u,
Tonga. 21 g was screened and the screen spectra of the 75% Me2CO/H2O fraction
contained resonances largely attributed to heteroaromatics. Further purification of this
fraction led to the isolation of known compounds makaluvamine G (55) and prianosin B
(56). The isolation of compounds 55 and 56 will be discussed in Chapter 4.
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Chapter 4
The Isolation of Known Compounds from Tongan
Sponges
4.1 Order Verongida
The lack of mineral spicules in the order Verongida makes their taxonomic identification
more difficult. Verongid sponges range in form, from tall tubular vases to thin spreading
crusts. Stalk formation is also a common feature. Verongids show a common marked
oxidative colour change at death or exposure to air, changing from yellow/yellow-green
to dark brown, or more frequently deep purple/black. Pigmentation in some sponges
is attributable to cyanobacteria. The order consists of four families: Aplysinidae,
Aplysinellidae, Ianthellidae and Pseudoceratinidae, as shown in Table 4.1.21 Verongids
are extremely distinct biochemically, they contain a vast array of bromotyrosine-derived
compounds, which occur in all genera that have been studied.21 In this study, two sponges
(Figures 4.1 and 4.6) were examined and were tentatively identified as Verongid sponges
based on their chemical constituents.
Table 4.1. Taxonomic Classification of the Order Verongida.21
Class Order Family
Demospongiae
Verongida
Aplysinidae
Aplysinellidae
Ianthellidae
Pseudoceratinidae
4.1.1 Bromotyrosine Derivatives
As mentioned before, marine sponges of the order Verongida have been noted to be a
rich source of bromotyrosine-derived secondary metabolites with interesting biological
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activities. The unusually large number of biosynthetically related compounds has been
linked to the potentially large number of chemical variations that are possible within
the aromatic ring and/or side chains of the tyrosine moiety. The aromatic ring can be
either maintained, reduced, oxidised or mono- or dibrominated.58–60 The bromotyrosine
moiety can also undergo rearrangement to a spirooxepinisoxaline system, presumably via
a common oxide intermediate as in the case of the psammaplysins.61–63 Alternatively,
the bromotyrosine can be rearranged to form the spirocyclooxazoline moiety, such as in
fistularins and aerothionin-1.64,65 The bromotyrosine units can also link up to form linear
chains through amide bonds as in the case of fistularin-3,64 or through ether bonds as
in the formation of macrocyclic bastadins.66–68 Currently, there are over 300 metabolites
isolated from Verongid sponges,69 and therefore the isolation of new metabolites from
these sponges is a real challenge.70,71
4.1.2 PTN3 33F
PTN3 33F was collected by snorkel from Ano Beach, Vava‘u, Tonga. The sponge was
massive, with a yellow-green pigmented surface and yellow interior (Figure 4.1). The
sponge oxidised rapidly to dark black at death. The sponge was extracted twice in MeOH
and the extracts were cyclic loaded onto reversed-phase PSDVB beads. The resin was
batch eluted with increasing amounts of Me2CO in H2O (Scheme 4.1). NMR examination
of the screen fractions showed that the interesting signals were confined to the 75%
Me2CO/H2O fraction, containing two major structural related compounds.
Figure 4.1. Surface photograph of the sponge PTN3 33F.
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ExtractSolids
MeOH (x2)
PTN3_33F  (27 g)
30% 75% 100%
HP20, Me2CO/H2O
80.6 mg 86.7 mg 75.8 mg
A B C
30% 40% 50% 60% 80% 100%
DIOL
Pet. Ether 50% 10% 30% 50%
HP20SS, Me2CO/H2O
3.1 mg 2.8 mg 4.4 mg 5 mg 9.7 mg 9 mg
Pet. ether
DIOL
CH2Cl2 EtOAc MeOH
50% 75% CH2Cl2 5% 15% 30% 50% MeOH
52.3 mg34.4 mg
5.1 mg
0.6 mg
7.1 mg
1.2 mg
    HPLC, C18 
85% MeCN/H2O
1.1 mg
51
50
    HPLC, C18, 
85% MeCN/H2O
G
E
D
EtOAc
fractions 39-41
F
H
Scheme 4.1. Isolation of aplysamine-2 (50) and aerophobin-1 (51) from PTN3 33E,
collected from Vava‘u, Tonga.
The HSQC screen spectrum (Figure 4.2) revealed interesting correlations from several
aromatic methines (δH 6.90–7.43; δC 113.1–134.7) and a number of deshielded
methylene (δH 3.43-4.08; δC 28.7-71.6) resonances, attributed to one major compound.
Analysis of the COSY correlations from these aromatic resonances allowed construction
of one spin system (Figure 4.3). This was supported by the characteristic coupling pattern
in the 1H NMR spectrum (Figure 4.4), which is consistent with a 1,2,4-trisubtituted
benzene ring (H-5: δH 7.44, d, 2.2 Hz; H-2: δH 6.90, d, 8.5 Hz; H-1: δH 7.18, dd,
2.2, 8.5 Hz). The 1H NMR spectrum, showed a signal of an isolated aryl proton (H-13:
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δH 7.43, 2H, br s), consistent with a symmetrically tetrasubstituted aromatic ring. Several
of the aromatic proton resonances showed further COSY correlations into the aliphatic
region of the spectrum. Purification of the 75% Me2CO/H2O fraction using NMR-guided
fractionation, led to the isolation of the compound. Comparision of the NMR data with
published data revealed the known compound aplysamine-2 (50). Compound 50 was
originally reported in 1989 from an Australian marine sponge Aplysina sp.72
Analysis of the HMBC (Figure 4.5) and HSQC screen spectra revealed interesting
correlations from several olefinic methines (δH 6.41–8.30; δC 117.7–135.4) and an
oxygenated methyl (CH3-15: δH 3.71; δC 60.4) and methine (CH-1: δH 4.08; δC 75.5),
attributed to the other major compound. COSY correlations from these olefinic methine
resonances revealed two individual spin systems. Inspection of the 1H, 13C, COSY and
HMBC NMR spectra suggested that the following proton signals belonged to the same
spin system (H-5: δH 6.41, H-1: δH 4.08, H-15: δH 3.71) and an AB system (H2-7:
δH 3.76 and δH 3.08) characteristic of a spirocyclooxazoline ring system previously
encountered in other Verongida compounds.65 The other spin system contained two
aromatic methines appearing as broad singlets at δH 7.15 (H-13) and 8.30 (H-14); which
showed weak COSY correlation to each other. In the HSQC spectrum, δH 7.15 and 8.30
have large 1JCH (198 Hz and 214 Hz repectively), which were consistent with coupling
constants of an imidazole ring. Further analysis of the NMR data and sub-structure
searchs of the literature revealed the known compound aerophobin-1 (51). Compound
51 was first isolated from marine sponge Verongia aerophoda.73
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Figure 4.2. HSQC NMR screen spectrum (600 MHz, CD3OD) of the 75% Me2CO/H2O
fraction of PTN3 33F.
Figure 4.3. COSY NMR screen spectrum (600 MHz, CD3OD) of the 75% Me2CO/H2O
fraction of PTN3 33F.
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Figure 4.4. 1H NMR screen spectrum (600 MHz, CD3OD) of the 75% Me2CO/H2O
fraction of PTN3 33F.
Figure 4.5. HMBC NMR screen spectrum (600 MHz, CD3OD) of the 75% Me2CO/H2O
fraction of PTN3 33F.
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4.1.3 PTN3 46E
PTN3 46E was a small creamy-pink sponge with thin spreading crusts, collected from
Tu‘ungasika Island, Vava‘u, Tonga in late November 2009 (Figure 4.6). Interestingly,
upon exposure to air or at death, no change in pigmentation was observed. The
sponge was extracted twice in MeOH and the extracts were cyclic loaded on to a
column of reversed-phase PSDVB resin. The resin was batch eluted with increasing
amounts of Me2CO in H2O and the fractions analysed by NMR. The 75% Me2CO/H2O
fraction appeared to contain one main compound and a mixture of structurally similar
compounds. Further chromatographic steps employing bench-top reversed- and normal-
phase chromatography (depicted in Scheme 4.2) led to the isolation of the three known
bromotyrosine compounds.
Figure 4.6. Underwater photograph of the sponge PTN3 46E. Courtesy of Karen Stone.
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ExtractSolids
MeOH (x2)
PTN3_46E  (27 g)
30% 75% 100%
HP20, Me2CO/H2O
136 mg 726.5 mg 105.5 mg
A B C
30% 40% 50% 60% 80% 100%5% 15% 30% 50% 5% 15% 30%
D
8.6 mg
Fractions 12-17 Fractions 28-33
6.2 mg
E
HP20SS, Me2CO/H2O
57.9 mg
F G H
5.3 mg 7.4 mg 3.3 mg 24.3 mg 11.1 mg 0.8 mg
5% 15% 30% 50% 75% 10%
I
2.2 mg
Fractions 13-17
J
1.8 mg
Fractions 31-37
5% 15% 30% 50% 5% 10%
K
0.7 mg
Fractions 7-17
L
0.8 mg
Fractions 25-32
5% 10% 15% 30% 50% 5%
M
18 mg
Fractions 26-31
52
53 54
53 5453 54
CH2Cl2 EtOAc MeOH
CH2Cl2 EtOAc MeOH CH2Cl2 EtOAc MeOH
SiO2
SiO2 SiO2
SiO2
CH2Cl2 EtOAc MeOH
Scheme 4.2. Isolation of fistularin-3 (52), aeroplysinin-1 (53) and LL-PAA216 (54)
from PTN3 46E, collected from Vava‘u, Tonga.
Initial analysis of the NMR spectra of the major compound showed characteristics of
a spirocyclooxazoline ring system (H-5: δH 6.42, H-1: δH 4.11, H-19 δH 3.73, and
an AB system (H-7: δH 3.78 and δH 3.10) as encountered in aerophobin-1 (51). The
compound also has a symmetrically tetrasubstituted aromatic ring (H-15: δH 7.62, 2H, bs)
similar to that of aplysamine-2 (50), thus identifying the major segments of the molecule.
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The HSQC spectrum revealed the presence of two highly polarised oxymethines (C-11
δH 4.11; δC 70.0: C-17 δH 4.77; δC 71.6) (consistent by their large 1JCH of 145 and
146 Hz). Further analysis of the NMR spectra (see Table 4.2 and Appendix E for NMR
data and spectra respectively) revealed fistularin-3 (52). In 1979, fistularin-3 (52) was
reported along with fistularin-1 (57) and fistularin-2 (58) from the marine sponge Aplysina
fistularis.64
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Analysis of the NMR spectra for the second bromotyrosine compound, initially suggested
the presence of another spirohexadienyl moiety. However, the chemical shifts of C-7
(δH 2.81, 2.85; δC 25.5) and C-8 (δC 116.6) in this compound were different from those
(H-7: δH 3.10, 3.78; C-7: δC 40.1; C-8: δC 155.1) of 52. In addition, the chemical
shift of the oxygenated spiro-carbon (C-6: δC 74.3) was considerably different from the
spirocarbon of the isoxazoline structure in compound 52 (C-6: δC 92.5). A correlation
was observed from the methylene proton H2-7 to N-10 in the
1H–15N HMBC spectrum.
The 15N chemical shift appears at –134.6, which is consistent with that of a nitrile,
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revealing 53 (see Table 4.3 and Appendix F for NMR data and spectra respectively). This
was confirmed by the positive-ion mode HRESIMS analysis of the compound, which
gave the molecular formula of C9H9NO3Br2 (359.8847 [M + Na]
+, ∆ 0.0 ppm) with
pseudomolecular ion clusters ([M + Na]+: [M + 2 + Na]+: [M + 4 + Na]+, requiring five
double-bond equivalents. Aeroplysinin-1 (53) was obtained from the sponge Verongia
aerophoba and is the first example of a naturally occurring 1,2-dihydroarene-1,2-diol.74
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Structural elucidation of the last bromotyrosine compound revealed a substructure similar
to that of fistularin-3 (52), but without the two spiroisoxazoline rings on either side (shown
in Figure 4.7). Therefore this was thought to be a novel derivative of 52. HRESIMS
of the compound showed a characteristic pseudomolecular ion cluster ([M + Na]+:
[M + 2 + Na]+: [M + 4 + Na]+: [M + 6 + Na]+: [M + 8 + Na]+) indicating a molecular
formula of C26H24N4O10Br4 (890.8124 [M + Na]
+, ∆ 0.0 ppm), requiring fifteen double-
bond equivalents. Since there were only 13 carbons reasonance observed in the 13C
NMR spectrum, the molecule was suspected to be a dimer with a symmetrical structure.
Attempted acetylation of the compound did not indicate the presence of any hydroxyl
groups. Therefore, the sample was re-submitted for mass analysis using both positive-
and negative-ion modes. Negative-ion mode HRESIMS analysis of the compound gave
rise to pseudomolecular ion clusters ([M − H]−: [M + 2 – H]–: [M + 4 – H]–, indicated
a molecular formula of C13H12N2O5Br2 (432.9035 [M − H]−, 0.0 ppm). The positive-
ion mode HRESIMS analysis of the compound gave the same molecular formula of
C13H12N2O5Br2 (456.9011 [M + Na]
+, ∆ 0.0 ppm) with pseudomolecular ion clusters
([M + Na]+: [M + 2 + Na]+: [M + 4 + Na]+, requiring eight double-bond equivalents.
Further analysis of the NMR spectra using the latter molecular formula with no hydroxyl
groups present, and comparision with published literature, revealed LL-PAA216 (54) (see
Table 4.4 and Appendix G for NMR data and spectra respectively). LL-PAA216 (54) was
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the first bromo-compound containing 2-oxazolidone, obtained from Verongia lacunosa,
collected off the coast of Puerto Rico in 1974.75 The problem encountered with the mass
spectrometry in this study was also encountered in zamamistatin.
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Figure 4.7. Proposed substructure of a compound isolated from PTN3 46E sponge.
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Zamamistatin, a novel bromotyrosine derivative, was obtained from the Okinawan sponge
Pseudoceratina purpurea in 2001 by Takada et al.76 In its ESIMS spectrum, zamamistatin
showed 1:4:6:4:1 quintet ion peaks at m/z 697, 699, 701, 703, and 705, indicative of the
presence of four bromine atoms with a molecular formula of C18H18Br4N2O6. Detailed
analysis of the NMR spectra suggested a symmetrical structure for zamamistatin as in
59. However, the chemical shift of the oxygenated spiro-carbon of zamamistatin (C-6:
δC 74.3) was considerably different from the spirocarbon of the isoxazoline structure
in aerothionin (60) (C-6: δC 91.5). Thus, an endo-type dimer of the azaoxa-spiro[6.6]
unit possessing a dihydro-1,2-oxazine ring, as shown in 61, was proposed as another
plausible structure in 2006 by Hayakawa et al.77 In 2008, Kita et al. revised the structure
of zamamistatin to that of the known compound aeroplysinin-1 (53), but not an exo- or
endo-type dimer 59 or 61 which were described previously.78
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The NMR data for fistularin-3 (52), aeroplysinin-1 (53) and LL-PAA216 (54) in the
literature are quite old and the 15N chemical shifts have not yet been published. Here
we report the NMR data for the three compounds (52–54) including the 15N chemical
shifts and the 1JCH values (Tables 4.2, 4.3, 4.4 and 4.5).
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4.2 Order Poecilosclerida
The order Poecilosclerida is the most diverse order of Porifera, both in terms of numbers
of species and morphology. The order belongs to the sub-class Ceractinomorpha,
which is characterised by a skeleton composed of both spicule and spongin fibres.
The order consists of 25 families, 129 genera and several thousands of described
species worldwide, distributed from intertidal to abyssal depths.21 The Latrunculia,
Strongylodesma, and Tsitsikamma of the family Latrunculiidae (Table 4.6) have a
characteristic base pigmentation of deep brownish black that is often and variously tinged
with forest green and deep blue. These specimens exude a dark brownish or greenish
black pigment; the ethanol preservative is always oily-looking and deeply pigmented.
Preserved specimens always retain their dark pigmentation.21
Table 4.6. Taxonomic Classification of Selected Families of the Order Poecilosclerida.21
Class Order Suborder Family Genus
Demospongiae
Poecilosclerida
Microcionina
Acarnidae
Zyzzya
Myxillina
Mycalina
Latrunculina
Latrunculiidae
Latrunculia
Sceptrella
Strongylodesma
Tsitsikamma
4.2.1 PTN4 10A
The sponge, PTN4 10A, examined in this study (Figure 4.8) was a massive, soft sponge
with deep black colour, both exterior and interior. The methanol extracts of the sponge has
a very dark greenish pigment. The sponge was extracted twice in MeOH and the extracts
were cyclic loaded on to a column of reversed-phase PSDVB resin. The resin was batch
eluted with increasing amounts of Me2CO in H2O and the fractions analysed by NMR
spectroscopy. The NMR spectra of the 75% Me2CO/H2O fraction appeared to contain
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interesting signals, attributed to two major compounds. Further chromatographic steps
employing bench-top normal-phase chromatography followed by reversed-phase HPLC
(depicted in Scheme 4.3) led to the isolation of two structurally related known compounds.
Figure 4.8. Underwater photo of the PTN4 10A sponge (courtesy of Karen Stone).
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90.6 mg 68 mg 60.8 mg
A B C
30% 40% 50% 60% 80% 100%
30%
HP20SS, MeOH/H2O
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17.9 mg 50 mg
0.6 mg 0.8 mg
56
55
    HPLC, C18, 
85% MeCN/H2O
D
E
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9.2 mg
CH2Cl2 EtOAc MeOH
Fractions 45-66
3.8 mg
60%
DIOL
50% 75% 10% 40% 80% MeOHCH2Cl2 EtOAc 20%
Fractions 21-22
0.6 mg
G
Scheme 4.3. Isolation of makaluvamine G (55) and prianosin B (56) from PTN4 10A,
collected from Vava‘u, Tonga.
One of the major compounds was isolated as a green-black solid. Inspection of the
HSQC screen spectrum indicated the presence of a large variety of deshielded aromatic
methines (δH 5.91–7.37; δC 85.6–130.5) and accompanied by two N-methyls (δH 3.86,
3.99; δC 35.0, 35.2) and two methylene resonances (δH 2.96–3.86; δC 18.1–42.7).
Substantial numbers of couplings from these 1H resonances were noted in the COSY
spectrum. Further analysis of the HMBC spectrum and comparision with published
47
literature indicated that is a discorhabdin-like compound, revealing makaluvamine G (55).
Compound 55, is a cytotoxic pigment originally reported in 1993 by Scheuer et al. from
an Indonesian sponge Histodemella sp.79 The first examples of the series, makaluvamines
A-F, were reported as cytotoxic pigments of a Fijian sponge Zyzzya cf. marsailis80 (an
incorrect spelling of massalis). The marine sponges Histodemella sp. and Z. cf. marsailis
were later re-idenified as Z. fuliginosa.81
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The other compound was isolated as red crystals. As for compound 55, several olefinic
methines (δH 7.55–8.31; δC 126.3–158.2) were observed in the HSQC spectrum. Several
of these olefinic methines showed correlations in the COSY spectrum. In addition, the
HSQC spectrum revealed two methylenes (CH2-7: δH 2.79, 2.97; δC 40.8 and CH2-4:
δH 2.79, 3.08; δC 46.5), which indicated the presence of chiral centres in the molecule.
Also of interest were two methines with large 1JCH values (CH-5: δH 4.72; δC 57.5, 1JCH
149 Hz and CH-8: δH 5.47; δC 62.6, 1JCH 163 Hz). In its HRESIMS spectrum, this
compound showed a molecular formula of C18H12N3OSBr, which taken together with
the detailed analysis of the NMR spectra, revealed this compound as prianosin B (56).
Compound 56, a sulfur-containing alkaloid with potent antineoplastic activity, was first
obtained from an Okinawan marine sponge Prianos melanos together with prianosins C
and D.82 The structures of prianosins C and D were later revised by Kobayashi et al.
in 1991 to known compounds 2-hydroxydiscorhabdin D (62) and discorhabin D (63),
respectively.83
In the past, chemotaxonomic trends within marine sponges producing pyrroloquinoline
metabolites have suggested that discorhabdins/prianosins and makaluvamines are defini-
tive chemotaxonomic markers for Latrunculia and Zyzzya species, respectively.84,85 Fur-
ther isolation of discorhabdin/prianosin and makaluvamine metabolites from other species
within the order Poecilosclerida suggest that this broad chemotaxonomic generalisation
may have to be treated with some circumspection. For the same reason, P. melanos has
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been re-identified as a species of Strongylodesma.21
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Figure 4.9. HSQC NMR screen spectrum (600 MHz, CD3OD) of the 75% Me2CO/H2O
fraction of PTN4 10A.
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Figure 4.10. COSY NMR screen spectrum (600 MHz, CD3OD) of the 75%
Me2CO/H2O fraction of PTN4 10A.
Figure 4.11. HMBC NMR screen spectrum (600 MHz, CD3OD) of the 75%
Me2CO/H2O fraction of PTN4 10A.
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4.3 Biological Activity
Fistularin-3 (52), aeroplysinin-1 (53) and prianosin B (56) were evaluated for cytotoxicity
against the human promyelocytic leukaemia cell line HL-60 at the School of Biological
Sciences, VUW. Compounds 52, 53 and 56 were found to be moderately cytotoxic
with IC50 values in the micromolar range (5.09 µM, 1.14 µM, 2.17 µM respectively).86
LL-PAA216 (54) has been submitted for biological testing to the School of Biological
Sciences at VUW, however the results are still pending.
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Chapter 5
Investigation of Fascaplysinopsis sp.
5.1 Fascaplysinopsis sp.
The genus Fascaplysinopsis belongs to the family Thorectidae, a member of the order
Dictyoceratida (Table 5.1). Dictyoceratids do not possess silicaceous spicules, which
makes their taxonomic identification more difficult. Thorectids are differentiated from
other members of the Dictyoceratida by their strongly laminated skeletal fibres, diplodal
choanocyte chambers, and lack of fine skeletal filaments. They range from low and
encrusting to massive in growth form and are distributed throughout tropical and
temperate oceans. Genera within Thorectidae are differentiated by the absence or
presence of a cortical armour.21 The genus Fascaplysinopsis has strong and thick primary
fibres, collagenous throughout the mesophyl of the sponge. They are found throughout
the Indo-Pacific. The Fascaplysinopsis sp. collected from Tongan waters in this study
was a massive globular sponge with a shiny red-brown appearance (Figure 5.1).
Table 5.1. Taxonomic classification of genus Fascaplysinopsis from Class
Demospongiae.21
Class Order Family Genus
Demospongiae
Dictyoceratida
Dysideidae
Irciniidae
Spongiidae
Thorectidae
Aplysinopsis
Cacospongia
Fasciospongia
Fascaplysinopsis
Hytrios
Luffariella
Thorectandra
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Figure 5.1. Surface photograph of the Fascaplysinopsis sp.
5.2 Chemical History of the Genus Fascaplysinopsis
Nitrogen-containing metabolites are not commonly observed from Dictyoceratid sponges,
as this order is known to be a rich source of di- or sesterterpenes, while family
Thorectidae are sources for both sesterterpenes and amino acid derivatives.26,87,88 The
first Fascaplysinopsis compounds reported were aplysinopsins (64 and 65), monomeric
tryptophan derivatives isolated from a marine sponge of the genus Aplysinopsis (now
considered a synonym of F. reticulata), which were unaccompanied by terpenoids.21,89
Fascaplysin (66), a pentacyclic pyridinium salt from the Fijian sponge Fascaplysinopsis
sp., was isolated alongside the known compound luffariellolide (45).90 The structure of
compound 66 was determined by spectral and X-ray analysis. Compound 66 inhibits the
growth of several microbes including Staphylococcus aureus, Escherichia coli, Candida
albicans, Saccharomyces cerevisiae, and showed cytotoxicity towards murine leukemia
L1210 cells with an IC50 of 0.2 µg/mL.90
Subsequently, several structurally related unusual alkaloid-sesterterpene salts have been
reported from the Fijian sponge F. reticulata, including fascaplysin A (67), fascaplysin B
(68), reticulatine A (69), reticulatine B (70) and homofascaplysin A (71), together with
sesterterpenoid anions dehydroluffariellolide diacid (72) and isodehydroluffariellolide
diacid (73).91,92 These compounds were accompanied by neutral alkaloids homofas-
caplysin B (74), homofascaplysin C (75), secofascaplysin A (76) and sesterterpene isode-
hydroluffariellolide (44).91,92 In 2003, analysis of the same sponge species collected from
Indonesia, obtained three compounds 3-bromofascaplysin (77), 14-bromoreticulatine
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(78), and 14-bromoreticulatate (79).93 Eight fascaplysin derivatives (80–87) were sub-
sequently isolated from the marine sponge F. reticulata collected off different locations in
Fiji and Indonesia.94
These fascaplysin derivatives were grouped into three main classes due to inconsistent
nomenclature in the current literature for tetracyclic and pentacyclic natural products.
The first class contains most structural variants closely related to 66, based on the
changes in the extent of conjugation present in the fused pentacyclic chromophore.94
These includes homofascaplysin B (74), homofascaplysin C (75), 3-bromofascaplysin
(77), 10-bromofascaplysin (80) , 3-10-dibromofascaplysin (81) and homofascaplysate A
(82). The other two classes were based on a single bond disconnection severing ring D
of the parent compound 66, as exemplified by the reticulatines (78, 79, 83–85) and the
secofascaplysins (76, 86, 87). Compound 80 exhibited human solid tumor selectivity
unlike compounds 66 and 84 showed significant selectivity for human leukemia.94 Other
studies revealed that compound 67 showed comparable activity in several tumor lines to
66 but the presence of the sesterterpene anion causes activity in some cell lines where 66
is inactive.94 Interestingly, the presence of a bromine in 77 produces an overall increase in
activity as compared to 66 and 67 but also causes inactivity in cell lines that are sensitive
to 66 and 67.94
A specimen of Fascaplysinopsis sp. from Palau contained the anti-inflammatory
sesterterpene palauolol (88), which was accompanied by known compounds palauolide
(89) and fascaplysin (66).95 Palauolol (88) was chemically recognised as being a
secondary alcohol that upon dehydration yields its known congener palauolide (89).
Compound 89 was first obtained as an antimicrobial sesterterpene from a three sponge
association collected in Palau which was later identified as Fascaplysinopsis sp.95,96 Two
closely related lipodepsipeptides, taumycins A and B (90 and 91) have been isolated
from an undescribed Fascaplysinopsis species from Madagascar.97 Taumycins A and B
(90 and 91) have the same 12-membered oxodepsipeptide ring system. Compound 90
shows cytotoxic activity against the human UT-7 leukemic cell line. In 2008, Bishara
et al. reported three nitrogenous macrolides salarin A and B (92 and 93) and tulearin
A (94) from the Madagascan sponge Fascaplysinopsis sp.98 A year later, the relative
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configuration of 92 was determined by X-ray diffraction.99 In 2010, the structure of
salarin B (93) was later revised to have a tetrahydrofuran ring system instead of the
16,17-diol.100 Tulearin A (94) carries a naturally rare carbamate ester, and its relative
and absolute configurations were determined by X-ray diffraction and modified Mosher’s
methods respectively.101 Both 92 and 94 exhibit cytotoxicity toward leukemia cell lines.98
Shortly thereafter, Bishara et al. reported salarin C (95) from the same Madagascan
sponge.102 Compound 95 is closely related to 92 and 93 and upon air oxidation, 95 was
found to transform to 92. Compound 95 was found to inhibit cell proliferation of human
leukemic and murine cell lines. Tulearins B and C (96 and 97) were reported in 2009
followed by tausalarin C (98), a novel bismacrolide.99,101 It is suggested that tausalarin C
(98) is assembled from salarin A and pretaumycin A. Salarins D-J (99–105) were reported
from the same Madagascan sponge by Bishara et al. in 2010, and are closely related
to salarins A–C.100 Salarins D (99), E (100), H (103) and J (105) showed significant
cytotoxic activity against human leukemia cells, while salarins F (101) and I (104)
were inactive. There are striking structural similarities of these metabolites to known
metabolites of microbial and fungal origin∗, suggesting that marine microorganisms may
be the true sources of these metabolites.105–107
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5.3 Isolation
A sponge identified as Fascaplysinopsis sp. was collected from an underwater cave off
the southwestern coast of ‘Eua, Tonga. The sponge was extracted twice in MeOH and
the methanolic extracts were cyclic loaded onto a column of reversed-phase PSDVB
beads. The resin was batch eluted with increasing amounts of Me2CO/H2O. NMR
examination of the eluted fractions showed that the interesting signals were confined
in the 30% and 80% Me2CO/H2O fractions. Further chromatographic steps employing
bench-top normal-phase chromatography followed by reversed-phase HPLC (depicted in
Scheme 5.1) led to the isolation of three known compounds, homofascaplysin A (43),
isodehydroisoluffariellolide (44), and luffariellolide (45), along with two novel com-
pounds, isoluffariellolide (46) and 1-O-methylisoluffariellolide (47). Homofascaplysin
A (43) and isodehydroluffariellolide (44) were originally isolated in 1991 from the Fijian
sponge Fascaplysinopsis reticulata,91 while luffariellolide (45) was first obtained from
the Palauan sponge Luffariella sp.108 Compound 43 was isolated in this study without the
sesterterpenoid anion.
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ExtractSolids
MeOH (x2)
Fascaplysinopsis sp. (200 g)
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HP20, Me2CO/H2O
96.1 mg
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A B C D E
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F G
C18, HPLC, 
85% MeCN/0.5 M HCOOH(aq) SiO2, CH2Cl2/EtOAc
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H
9  mg
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75.7 mg
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K L
J
0.2 mg
  C18,  HPLC,  
95% MeCN/H2O
24.5 mg
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47
44 45,46
3.3 mg1.2 mg0.4 mg 0.5 mg
Fractions 33-36
I
Scheme 5.1. Isolation of homofascaplysin A (43), isodehydroluffariellolide (44),
luffariellolide (45), isoluffariellolide (46) and 1-O-methylisoluffariellolide (47) from
Fascaplysinopsis sp. collected from ‘Eua, Tongatapu.
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5.4 Isoluffariellolide
Isoluffariellolide (46) was isolated as stable, light yellowish oil. Accurate mass mea-
surement of the molecular formula C25H38O3 was determined for 46 by HRESIMS
with the [M + Na]+ pseudomolecular ion at m/z 409.3471 (∆ 0.1 ppm), requiring seven
double bond equivalents. Despite repeated chromatography, compound 46 was always
accompanied by a small amount of compound 45 (∼18%) as illustrated in the 1H
NMR spectrum (see Appendix B). 1H NMR resonances were observed for H-1 and H-
3 attributed to 45 (δH 6.00 and 5.85 ppm respectively) and H-1 and H-2 attributed to 46
(δH 6.84 and 6.10 ppm respectively).
The 13C NMR spectrum of 46 contained 24 distinct resonances while the 1H NMR
spectrum accounted for 37 of the 38 protons. An HSQC experiment confirmed the
attachment of 37 of these protons to carbon, indicating the presence of one exchangeable
proton. All 25 carbon resonances were identified through interpretation of the 1H and
HSQC NMR spectra; five methyls (δC 16.2; 16.3; 20.0, 28.8, 28.8), nine methylenes
(δC 19.7; 25.3; 25.7; 26.7; 28.1; 32.9; 39.8; 40.0; 40.4), three olefinic methines (δC 122.5;
123.5; 143.6), one oxymethine (δC 96.9), and seven quartenary carbons (δC 35.1; 127.1;
136.4; 137.2; 137.3; 138.1; 171.8) (Table 5.3).
COSY correlations between methylene H2-18 (δH 1.90; δC 32.9) and methylene H2-
17 (δH 1.55; δC 19.7), and between H2-17 and methylene H2-16 (δH 1.40; δC 40.0)
established the methylene chain C-16 to C-18. HMBC correlations from H2-18 to C-
16 and C-17, in conjunction with HMBC correlations from H2-16 to C-17 and C-18
confirmed these connections (Figure 5.2).
18
16
COSY
HMBC
Figure 5.2. COSY and HMBC correlations establishing connectivity of C-16 to C-18 of
isoluffariellolide (46).
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Analysis of the HMBC spectrum revealed that H2-18 showed three other correlations to
C-14 (δC 137.2), C-19 (δC 127.1), and CH3-20 (δH 1.60; δC 20.0). The singlet
1H
signal of CH3-20 indicates attachment to a double bond at a quartenary carbon. This
was confirmed by HMBC correlations from H3-20 to C-14, C-18, and C-19. An HMBC
correlation from H2-17 to C-19 firmly established the connectivity between C-18 and
C-19, as well as the attachment of CH3-20 to C-19. A six-proton methyl singlet at CH3-
21/CH3-22 (δH 0.99; δC 28.8) was assigned as a gem-dimethyl pair, connected to the
alkyl quaternary carbon C-15 which in turn is adjacent to C-14 and C-16 on either side. An
HMBC correlation observed from H-16 to C-14 and C-15, confirmed this connection. The
HMBC correlations from H3-21/22 to C-14, C-15, and C-16 suggested that substructure
A (depicted in Figure 5.3), is a trimethylcyclohexenyl ring, which is also encountered in
luffariellolide, the mokupalides and the luffariolides.108–110
CH3H3C
CH318
16
19
14
21 22
20
HMBC
Figure 5.3. HMBC correlations establishing connectivity of the trimethylcyclohexenyl
ring system, substructure A, of isoluffariellolide (46).
Methylene protons H2-13 (δH 2.04; δC 28.1) showed HMBC correlations to C-14 and
C-19, indicating the connection between C-13 and C-14. Vicinal couplings between H2-
13 and methylene protons H2-12 (δH 1.99; δC 40.4) extended the fragment further and
provided the connection between C-12 and C-13. HMBC correlations observed from H2-
13 to C-12 and H2-12 to C-13 confirmed this connection. Analysis of the HMBC spectrum
showed two correlation from H2-12 to a quartenary olefinic carbon C-11 (δC 136.4) and
to a olefinic methine CH-10 (δH 5.10; δC 123.5) suggesting a trisubstituted double bond.
The methyl singlet CH3-23 (δH 1.63; δC 16.2) must be connected to C-11, which is
supported by a HMBC correlation from H3-23 to C-11. HMBC correlations from H3-23
to C-12 and C-10 confirmed this connection, which was further supported by a long-range
COSY correlation between H-10 to H3-23, establishing substructure B (Figure 5.4).
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Figure 5.4. COSY and HMBC correlations establishing connectivity of C-10 to C-13,
substructure B, of isoluffariellolide (46).
A similar substructure was revealed in the COSY spectrum from a correlation between
the two methylenes CH2-9 (δH 2.08; δC 26.7) and CH2-8 (δH 2.00; δC 39.8) as the
two methylenes show vicinal coupling to each other. This connection was confirmed by
HMBC correlations from H2-9 to C-8 and H2-8 to C-9. The assignment of C-10 and C-9
as adjacent carbons was supported by HMBC correlations from H2-9 to C-10 and C-11,
and H-10 to C-9, strong correlations from H2-8 to an olefinic carbon C-7 (δC 137.3) and
to an olefinic methine CH-6 (δH 5.10; δC 122.5). Again a trisubstituted double bond was
established using HMBC correlations from CH3-24 (δH 1.61; δC 16.3) to CH-6, C-7 and
C-8, establishing substructure C (Figure 5.5).
Due to spectral overlap, NOE enhancements were of limited utility in determining the
geometry of the double bonds. Fortunately, methyl groups (CH3-23 and CH3-24) on the
trisubstituted double bonds show characteristic NMR shifts: δH <1.6 and δC <20 for
the E, and δH >1.6 and δC >20 for Z geometry.111 Thus, the methyl groups revealed the
double bonds ∆6,7 and ∆10,11 to both have E geometry.
CH3
H
9 7
6
COSY
HMBC
24
H
CH3
23
10
CH3
CH3H3C
Figure 5.5. COSY and HMBC correlations establishing connectivity of C-6 to C-9,
substructure C, of isoluffariellolide (46).
COSY correlations between two methylenes CH2-5 (δH 2.26; δC 25.7) and CH2-4
(δH 2.35; δC 25.3), and HMBC correlations from H2-5 to C-4 and H2-4 to C-5, indicated
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the linkage between C-5 and C-4. An HMBC correlation from H2-5 to C-6 and C-7 was
evident, confirming the connectivity of C-5 and C-6. Analysis of the HMBC spectrum
showed extra correlations from H2-4 to three carbons: a carbonyl C-25 (δC 171.7), an
olefinic carbon C-3 (δC 138.1), and an olefinic methine carbon CH-2 (δH 6.84; δC 143.6),
suggesting that C-4 is adjacent to C-3. The deshielded shift of carbon C-25 suggested
the presence of an α,β-unsaturated lactone unit. The HMBC correlations from H-2 to
C-25, C-3 and CH-1 (δH 6.10; δC 96.9), in conjunction with the HMBC correlation
from H-1 to C-25 and C-3 formed a γ-hydroxybutenolide ring, which accounted for
the last remaining three double bond equivalents. The α,β-unsaturated carbonyl shields
the α-carbon and deshields the β-carbon. This places CH-2 at the β-position, and the
alkyl attachment at C-3. An excellent confirmation of this assumption arose from the
homoallylic relationship between H-1 and H2-4, illustrated by an
1H-1H COSY long range
correlation. This established substructure D (depicted in Figure 5.6), as an α-substituted-
γ-hydroxybutenolide ring.
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25
1
COSY
HMBC
H
CH3
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24
Figure 5.6. COSY and HMBC correlations establishing connectivity of the
α-sustituted-γ-hydroxybutenolide ring, substructure D, of isoluffariellolide (46).
The NMR data for the γ-hydroxybutenolide ring for isoluffariellolide (46) was compared
to that of luffariellolide (45)108 and dictyodendrillin C (106)112 to ensure the correct
structural isomer of 46 was assigned (Table 5.2). In 46 and 106, an α-substituted-α,β-
butenolide ring is proposed, while 45 contains a β-substituted-α,β-butenolide ring. The
substitution position affects the proton chemical shifts of the olefinic methine proton
and the oxymethine proton. In 46, the olefinic methine proton appears at δH 6.84
ppm compared to δH 5.85 ppm in 45. The oxymethine proton in 46 appears at 6.10
ppm compared to 6.01 ppm in 45. Thus, the substitution on the α-position of the γ-
hydroxybutenolide ring, as opposed to the β-position, causes the downfield shift of the
H-2 and H-1 resonances in the 1H NMR spectrum. This also has a great effect on the
chemical shifts of the olefinic methine carbon and the quartenary olefinic carbon. The
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olefinic methine carbon in 46 appears at δC 138.1 ppm and resonates at δC 117.0 ppm
in 45, whilst in 45, the quartenary olefinic carbon appears at δC 169.9 ppm compared to
δC 138.1 ppm in 46. Both carbons showed dramatically changed chemical shifts. Thus,
the substitution point on the γ-hydroxybutenolide ring system greatly affected the 1H and
13C chemical shift for the α- and β-position. The 1H and 13C NMR data for 46 were
consistent with that for 106, supporting the substitution at the α-position. Therefore the
structure of isoluffariellolide is given as 46 with NMR data presented in Table 5.3.
OO
OH
106
Table 5.2. Comparison of the 1H and 13C NMR chemical shifts (CDCl3) of the
γ-hydroxybutenolide ring of luffariellolide (45), isoluffariellolide (46), and
dictyodendrillin C (106).
O
O
OH
12
3 25
45
O
O
OH
12
3
25
46
O
O
OH
12
3
15
106
1H 13C
Position 45 46 106 45 46 106
1 6.01 6.10 6.07 99.5 96.9 96.7
2 6.84 6.83 169.9 143.6 143.6
3 5.85 117.0 138.1 137.7
25 (15†) 171.9 171.7 171.1†
†Assigned as carbon 25 (C-15).
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5.5 1-O-Methylisoluffariellolide
1-O-Methylisoluffariellolide (47) was isolated as a light yellowish oily residue. Positive-
ion mode HRESIMS analysis of 47 showed a characteristic pseudomolecular ion peak at
m/z 423.2867 ([M + Na]+, ∆ 0.0 ppm), indicative of a molecular formula of C26H40O3,
requiring seven double-bond equivalents. The molecular formula for compound 47 differs
from luffariellolide (45) and isoluffariellolide (46) by a CH2 unit, supporting the gain of
one oxymethyl group as indicated by the appearance of a deshielded methyl resonance
(δH 3.55, δC 57.0) in the NMR spectra of 47.
The 13C NMR spectrum contained 26 distinct carbon resonances while the 1H NMR
spectrum accounted for all 40 protons, which a multiplicity-edited HSQC experiment
confirmed were all attached to carbon. A detailed analysis of the 13C, HSQC and HMBC
NMR spectra of 1-O-methylisoluffariellolide (47) (Table 5.4) assigned all 26 carbons in
the molecule; five methyls (δC 16.2; 16.3; 20.0, 28.8, 28.8), nine methylenes (δC 19.7;
25.5; 25.6; 26.7; 28.1; 32.9; 39.8; 40.0; 40.4), three olefinic methines (δC 122.5; 123.5;
142.2), one oxymethyl (δC 57.0), one oxymethine (δC 102.6), and seven quartenary
carbons (δC 35.1, 127.1; 136.3; 137.2; 137.3; 138.5; 171.6).
The structure of 47 was elucidated in a similar fashion to isoluffariellolide (46), beginning
at the methylene chain in the trimethylcyclohexenyl ring. A series of sequential
COSY correlations were observed starting from methylene proton resonances of CH2-
18 (δH 1.90; δC 32.9) to a second methylene proton H2-17 (C-17: δC 19.7; δH 1.55),
and between H2-17 to third methylene proton H2-16 (δH 1.40; δC 40.0) established the
methylene chain C-16 to C-18. This was confirmed through two and three bond HMBC
correlations between CH2-16, CH2-17, and CH2-18 (Figure 5.7).
18
16
COSY
HMBC
Figure 5.7. COSY and HMBC correlations establishing connectivity of C-18 to C-16 of
1-O-methylisoluffariellolide (47).
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Further analysis of the HMBC spectrum showed another three correlations from H2-16 to
quartenary sp3 carbon C-15 (δC 35.1), olefinic quaternary carbon C-14 (δC 137.3), and
gem-dimethyl carbons CH3-21/22 (δH 0.99; δC 28.8). The gem-dimethyl singlet showed
strong HMBC correlations to C-14, C-15, C-16, suggested that they are connected to the
alkyl quaternary carbon (C-15), which in turn is adjacent to C-16 and C-14 on the other
sides. The methylene protons H2-18 also exhibited HMBC correlations to C-14 and C-19
(δC 127.1), suggesting C-19 placement on the other side, establishing the presence of a
fully substituted double bond. An HMBC correlation from methyl singlet proton CH3-
20 (δH 1.60; δC 20.0) to C-19 confirmed this connection and established substructure
A (depicted in Figure 5.8), as a trimethylcyclohexenyl ring which is also observed in
isoluffariellolide (46).
CH3H3C
CH318
16
19
14
21 22
20
HMBC
Figure 5.8. HMBC correlations establishing connectivity of the trimethylcyclohexenyl
ring moiety, substructure A, of 1-O-methylisoluffariellolide (47).
HMBC correlations observed from H2-13 (δH 2.04; δC 28.1) to C-14 and C-19, indicating
the connection between C-13 and C-14. Observation of a COSY correlation between
methylene proton H2-13 and methylene protons of CH2-12 (δH 1.98; δC 40.4) extended
the partial structure, shown in Figure 5.10. An HMBC correlation from H2-13 to C-
12 and from H2-12 to C-13, confirmed this assignment between C-13 to C-12. Further
HMBC correlations from H2-12 to olefinic carbon C-11 (δC 136.3) and olefinic methine
CH-10 (δH 5.10; δC 123.5), suggested the presence of another trisubsituted double bond
(C-11 to C-10). The methyl singlet carbon CH3-23 (δH 1.63; δC 16.2) placement on
the double bond was established through HMBC correlations from methyl proton H3-23
to C-11 and C-10. An HMBC correlation from olefinic methine proton H-10 to C-23
established the connection between C-11 and C-10, and the adjacent of C-23 to the non-
protonated olefinic carbon C-11. Analysis of the COSY spectrum showed long range
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coupling from olefinic methine proton H-10 to methyl proton H3-23 that confirmed this
connection (Figure 5.9).
CH3
H
13
12
11
10
COSY
HMBC
23
CH3H3C
CH3
14
19
Figure 5.9. COSY and HMBC correlations establishing connectivity of C-9 to C-6 of
1-O-methylisoluffariellolide (47).
Two further methylenes (C-9: δH 2.06; δC 26.7, C-8: δH 2.00; δC 39.8) were placed
next to the double bond (C-11 to C-10) based on COSY correlations observed from H-
10 to H2-9 and from H2-9 to H2-8. Together with an HMBC correlation from olefinic
methine proton H-10 to C-9, this confirmed the placement of adjacent C-10 and C-
9. An HMBC correlation from H2-9 to C-8 and H2-8 to C-9 confirmed the connection
between C-9 and C-8. The methylene proton H2-8 showed extra HMBC correlations to
two carbons; non-protonated olefinic carbon C-7 (δC 137.2) and olefinic methine carbon
CH-6 (δH 5.09; δC 122.5). Unsurprisingly, the structure was unveiling itself as another
isopropene unit with HMBC and COSY correlations establishing the presence of another
trisubstituted double bond. The methyl singlet proton H3-24 (δH 1.60; δC 16.3) showed
HMBC correlations to C-6 and C-7 which confirmed this assignment. This established
substructure B, as depicted in Figure 5.10.
Due to spectral overlap, NOE enhancements were of limited utility in determining the
geometry of the double bonds. The methyl groups (CH3-23 and CH3-24) on the isolated
trisubstituted double bonds show characteristic NMR shifts: δH <1.6 and δC <20 for
the E, and δH >1.6 and δC >20 for Z geometry.111 Based on this, and the similarity of
chemical shifts with related compounds (same in 46), the double bonds ∆6,7 and ∆10,11
were assigned as E.
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Figure 5.10. COSY and HMBC correlations establishing connectivity of C-13 to C-6,
substructure B, of 1-O-methylisoluffariellolide (47).
The substructures A and B accounted for four double bond equivalents suggesting the
compound contained a ring system and two double bonds. COSY correlations observed
between two methylenes CH2-5 (δH 2.25; δC 25.6) and CH2-4 (δH 2.33; δC 25.5), and
HMBC correlation from H2-5 to C-4 and H2-4 to C-5 indicated the placement between
C-5 and C-4. HMBC correlations from H-5 to C-7 and C-6 was evident, confirming
the connectivity of C-5 and C-6. The methylene proton H2-5 and H2-4 showed HMBC
correlations to an olefinic carbon C-3 (δC 138.5), establishing the connectivity between
C-3 and C-4.
Further analysis of the HMBC spectrum showed correlations from H2-4 to an ester
carbonyl carbon C-25 (δC 171.6) and olefinic methine carbon CH-2 (δH 6.76; δC 142.2).
HMBC correlations from olefinic methine proton H-2 to C-25, C-3, CH-1 (δH 5.72;
δC 102.6), CH2-4, and from oxymethine proton H-1 to C-25 and C-3, suggested the
presence of an α,β-butenolide ring. A series of COSY correlations between H-2, H-1 and
H2-4 placed C-4 at the α-position of the butenolide. The butenolide ring system accounted
for the last remaining three double bond equivalents. HMBC correlations from oxymethyl
proton H3-26 to C-1, placed an oxymethyl at the γ-position of the butenolide ring instead
of a hydroxyl group as observed in 46 (Figure 5.11).
O
O
H
O
H
5
4
3
25
1
COSY
HMBC
H
CH3
6
24 CH3
Figure 5.11. COSY and HMBC correlations establishing connectivity of the
α-substituted-γ-methylbutenolide ring, substructure C, of 1-O-methylisoluffariellolide
(47).
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The presence of an upfield non-protonated olefinic carbon and a downfield olefinic
methine, suggested that it is an α-substituted butenolide ring. The NMR data for the
butenolide ring for 1-O-isoluffariellolide (47) was also compared to that of isoluffariel-
lolide (46), 25-O-methylluffariellolide (107)113 and 1-O-ethylhyrtiolide (108)114 to ensure
the correct structural isomer of 47 was assigned (Table 5.4). Firstly comparing 46 and
47, the only signficant difference in the 13C NMR spectrum is C-1, which is shifted
downfield by approximately 6 ppm in 47. This change in chemical shift is consistent
with carbon substitution of the free hydroxyl group. Compound 47 is substituted on the
α-position (same in 46 and 108) while 107 is a β-substituted butenolide ring. In 47,
the olefinic methine proton appears at δH 6.76 ppm and resonates at δH 5.91 ppm in
107. The substitution on the α-position of the butenolide ring, as opposed to the β-
position, caused the downfield shift of the olefinic methine in the 1H NMR spectrum. The
substitution position also affected the chemical shifts of the olefinic methine carbon and
non-protonated olefinic carbon. In 47, the olefinic methine carbon appears at δC 142.2
ppm and resonates at δC 118.8 ppm in 107, whilst in 107, the non-protonated olefinic
carbon appears at δC 170.0 ppm compared to δC 138.5 ppm in 47. The substitution of the
butenolide ring does not affect the chemical shifts of C-1 and C-25. The 1H and 13C NMR
data for 47 were consistent with that of 108, supporting the substitution on the α-position
(C-3). Therefore the structure of 1-O-methylisoluffariellolide is given as 47 with NMR
data presented in Table 5.4.
O
O
OMe
107
OO
OEt
108
71
Table 5.4. Comparison of the 1H and 13C NMR Chemical Shifts of the Butenolide Ring
of Isoluffariellolide (46), 1-O-Methylisoluffariellolide (47), 25-O-Methylluffariellolide
(107), and 1-O-Ethylhyrtiolide (108).
O
O
OH
12
3
25
46
O
O
OMe
12
3
25
47
O
O
OMe
12
3 25
107
O
O
OEt
12
3
25
108
1H 13C
Position 46 47 107 108 46 47 107 108
1 6.10 5.72 5.78 5.78 96.9 102.6 106.3 101.5
2 6.84 6.76 6.75 143.6 142.2 170.0 142.2
3 5.91 138.1 138.5 118.8 138.1
25 171.7 171.6 172.0 171.5
Compounds 46, 47 and 108 were recorded in CDCl3 whilst 107 was
recorded in CD3OD.
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5.6 Biological Activity
Isodehydroluffariellolide (44), isoluffariellolide (46) and 1-O-methylisoluffariellolide
(47) were submitted for cytotoxicity testing at the School of Biological Sciences, VUW.
They were tested in a 48 hour MTT assay against HL-60 (leukemia) cells. Compounds
44, 46 and 47 were found to be moderately cytotoxic with IC50 values in the micromolar
range (12.21 µM, 29.63 µM and 5.09 µM respectively).86
5.7 Related Compounds
Many primary and secondary metabolites are derived from terpenes, all biosynthesised
from the five-carbon isoprene building units.115 Structural modification of these isoprene
units leads to a diverse range of derivatives with unique chemical structures and biological
properties. Triterpenoids were the first terpenoids reported from marine resources and
since then a vast array of derivatives have been documented. Marine sponges have been
identified as one of the prime resources of sesterterpenes.116
Manoalide (109) is the parent compound of a series of marine sponge metabolites
belonging to the sesterterpene class and probably the most well known of all sestert-
erpene sponge metabolites. Manoalide (109) was originally isolated by Scheuer et
al. in 1980 from the sponge Luffariella variabilis collected in Palau.117 One year
later, Scheuer et al. reported three additional related metabolites from the same
Palauan sponge, secomanoalide (110), (E)-neomanoalide (111) and (Z)-neomanoalide
(112).118 All four compounds (109–112) exhibit antibiotic activity.119 Later, marine
sponges of the family Thorectidae, including species of the genera Hyrtios,114,120,121
Cacospongia,122,123 Thorectandra,124,125 Fasciospongia,126–129 Luffariella,108,110,118,130–140
Aplysinopsis,141 and Acanthodendrilla,113 were also found to be rich sources of novel
bioactive sesterterpenoids closely related to 109.
Early studies into the pharmocology of 109 revealed an irreversible inhibition of
phospholipase A2.
142,143 Subsequently, many related metabolites with PLA2 inhibitory
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activity were also reported, which attracted scientific interest to study the structure-
activity relationships (SAR) of 109 to understand both PLA2 function and mechanism
of action in the whole cell.108,144–150 Several studies revealed the contribution of various
functional groups incorporated in 109 and its analogues, such as the γ-hydroxybutenolide,
α-hydroxydihydropyran and trimethylcyclohexenyl ring systems, to the efficacy as PLA2
inhibitors.146,150,151
Manoalide-25-monoacetate (113) was reported in 1988 from the marine sponge Thorectan-
dra excavatus.124 24-O-Ethylmanoalide (114) was isolated from Luffariella cf. variabilis
collected from the Indian Ocean,140 while 24-O-propylmanoalide (115) was obtained
from the Palauan sponge L. variabilis.138 (4E,6E)-Dehydromanoalide (116) was obtained
from the Palauan sponge L. variabilis and showed reduced potency but similar efficacy to
that of 109 against bee venom PLA2 (IC50 = 0.28 µM).134,151 Two diastereomers of 24-
O-methylmanoalide (117 and 118) and (6Z)-neomanoalide-24,25-diacetate (119) were
isolated from a sponge of the genus Luffariella.136 Compounds 117 and 118 exhibited
antibacterial activity. Four new antibacterial sesterterpenes (120–123) were reported from
a marine sponge of the genus Luffariella collected from the Australian Great Barrier
Reef.133
An investigation of the Fijian sponge F. reticulata led to the isolation of isodehydroluf-
fariellolide (44) and dehydroluffariellolide diacid (72).91 Fasciospongide A (124) was
obtained from the New Caledonian sponge Fasciospongia sp.126 Bioassay-directed sepa-
ration of an extract of a Thorectandra sp. sponge led to isolation of 16-oxoluffariellolide
(125), 16-hydroxyluffariellolide (126), and compound 127, all with phosphatase Cdc25B
inhibitory activity.125 Compounds 44, 124 and 125 possessed a substituted trimethylcy-
clohexenone ring moiety instead of a trimethylcyclohexenyl ring system found in 109 and
other analogues. Luffariellolide (45) is a sesterterpenoid analogue of 110, which was first
reported by Faulkner et al. in 1987 from the Palauan marine sponge Luffariella sp.108
In contrast with the irreversible inhibitory action of 109 towards PLA2, luffariellolide
(45) is a slightly less potent, but a partially reversible PLA2 inhibitor, which meant
that 45 became a more preferable anti-inflammatory agent for potential pharmacological
investigation.108
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In addition to luffariellolide (45), its 25-O-methyl (107) and 25-O-ethyl derivatives (128),
five cytotoxic acantholides A-E, were isolated from the Indonesian sponge Acantho-
dendrilla sp.113 Acantholides A (129) and B (also reported as 16-oxo-luffariellolide,
125) possessed both the trimethylcyclohexene and the γ-hydroxybutenolide moieties.
Acantholides D (130) and E (131) are derivatives comprising the 1-acetylcyclopentan-5-ol
moiety, and are rare variants for the C14-C20 segment in this type of linear sesterterpenes
thus replacing the trimethylcyclohexenyl ring. Luffariellolide (45) and its 25-O-methyl
congener (107), as well as acantholide E (131), were cytotoxic against the mouse
lymphoma L5178Y cell line with ED50 values of 3.3, 0.7, and 7.0 µg/mL, respectively.
Interestingly, these results suggested that the 25-O-methyl group in compound 107 and
the stereochemistry of 1-acetylcyclopentan-5-ol in 131 play an important role in the
cytotoxicity of the compound.113
Luffariolides A-J (132–140), are a related group of sesterterpenoidal analogues, have been
isolated from different collections of the Okinawan marine sponge Luffariella sp.110,130,139
All luffarieolides exhibited significant cytotoxicity against the murine lymphoma L1210
cell line with IC50 values ranging between 1.1–7.8 µg/mL. Luffariellins A (141) and
B (142) were isolated from the marine sponge L. variabilis collected in Palau.131
Chemical investigation of the same sponge species collected from the Great Barrier
Reef, Australia, yielded three new acetylated compounds, 25-acetoxyluffariellin A (143),
25-acetoxyluffariellin B (144), and 25-acetoxysecomanoalide (145).137 Luffariellins C
(146) and D (147) were obtained from the nudibranch Chromodoris funerea collected
from Palau.152 Luffariellins (141–144) are all characterized by the 1-isoproprenyl-2-
methylcyclopentane ring system replacing the trimethylcyclohexenyl moiety in other
manoalide analogs. Despite this difference in chemical structure, luffariellins A (141)
and B (142) retain identical functional groups as present in 109 and 110, respectively.
Therefore, not surprisingly, each respective pair was shown to have similar anti-
inflammatory properties to 109 and 110.131
Hyrtiolide (148) and its 1-O-ethyl derivatives (108) were obtained sponge Hyrtios cf.
erecta, from Fiji.114 Aplysinoplides A–C (149–151) were isolated from the marine sponge
Aplysinopsis digitata.141 Compounds (149–151) exhibited cytotoxic activity against P388
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mouse leukemia cell lines with IC50 values of 0.45, 0.45, and 11 µg/mL, respectively. In
a parallel experiment, aplysinoplides A (149) and B (150) did not inhibit bovine pancreas
PLA2 at a concentration of 100 µM, whereas manoalide (109) exhibited a potent activity.
These results suggested the important role of the C-24 aldehyde for inhibition of PLA2.
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Chapter 6
Investigation of Sponge from the Order Dictyoceratida
6.1 Order Dictyoceratida
The order Dictyoceratida, which belongs to the class Demospongiae, does not have any
silicaceous spicules, which makes taxonomic identification of the dictyoceratid sponges
more difficult. Dictyoceratid sponges are tough and flexible, with typical conulose
surface, marked by concules or cone-shaped elevations. These sponges often have a
marked difference in external and internal pigmentation with a dark exterior and the
interior ranging from white, cream, through to pale brown or yellow. The order consists of
four families: Dysideidae, Spongiidae, Irciniidae and Thorectidae (Table 6.1).21 In terms
of chemotaxonomy, the order is characterised by a diverse range of terpenes and very low
sterol content.21 The taxonomy of the Dictyoceratida has been revised multiple times,21
and a full review of the secondary metabolites isolated from dictyoceratid sponges is
beyond the scope of this report.
The sponge investigated in this study (shown in Figure 6.1) was a encrusting sponge with
upright fingers. The sponge is soft with a slippery texture. It was pale grey on the surface
with mid–brownish interior. It contained no silicaceous spicules, and has tentatively been
identified as belonging to the order Dictyoceratida.
Figure 6.1. Surface photograph of the sponge PTN3 21C.
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Table 6.1. Taxonomic classification of the order Dictyoceratida.21
Class Order Family Genus
Demospongiae
Dictyoceratida
Dysideidae
Irciniidae
Spongiidae
Thorectidae
Aplysinopsis
Cacospongia
Fasciospongia
Fascaplysinopsis
Hytrios
Luffariella
Thorectandra
6.2 Isolation
An undescribed dictyoceratid sponge (PTN3 21C), was collected from an underwater
cave at the southwest of ‘Eua, Tonga. The sponge was extracted twice in MeOH and
the extracts were cyclic loaded onto reversed-phase PSDVB beads. The resin was batch
eluted with increasing amounts of Me2CO in H2O. NMR examination of the screened
fractions showed that the interesting signals were confined to the 75% Me2CO/H2O
fraction. Further chromatographic steps employing reversed-phase HPLC (depicted in
Scheme 6.1) led to the isolation of the known thorectolide (48), and a novel sesterterpene,
secothorectolide (49). Use of HPLC led to the isolation of two impure compounds with
a very similar chromophore. Preliminary NMR analysis of fractions D and E (Scheme
6.1) showed similarites to each other, however the aldehyde proton that appears in the
1H NMR spectrum of fraction D was absent in fraction E. Mass spectroscopy indicated a
molecular formula of C25H36O5 for fraction E, and a literature search of the sesterterpene
class and comparison of the NMR data revealed the compound to be thorectolide (48).
Compound 48 was reported from a New Caledonian sponge Hyrtios sp. in 1996.120
OHO O
O
OH
48
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ExtractSolids
MeOH (x2)
PTN3_21C  (26 g)
30% 75% 100%
HP20, Me2CO/H2O
41.9 mg
20 mg 61.9 mg 63.7 mg
A B C
5.4 mg 3.9 mg 3.4 mg
D E
C18, HPLC, 85% MeCN/H2O
2.9 mg 4.0 mg 3.7 mg
F G
0.7 mg 2.7 mg 0.2 mg 1.6 mg
C18, HPLC, 85% MeCN/H2O
   C18, HPLC, 
85% MeCN/H2O
0.3 mg 0.6 mg 0.5 mg 0.5 mg
49 48
Scheme 6.1. Isolation of thorecetolide (48) and secothorectolide (49) from PTN3 21C,
collected from ‘Eua, Tongatapu.
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6.3 Secothorectolide
The observation of a pseudomolecular ion by positive-ion mode HRESIMS indicated a
molecular formula of C25H36O5 for compound (49) (m/z 439.2460, [M + Na]+, ∆ 0.0
ppm), which requires eight double bond equivalents. Examination of the 13C NMR
spectrum revealed only 24 resonances, however the carbon signal observed at 170.3 ppm
accounted for two different carbons, thereby accounting for all 25 carbons suggested by
the molecular formula. The 1H NMR spectrum accounted for 34 protons, suggesting two
exchangeable protons. Analysis of the HSQC spectrum confirmed the attachment of these
34 protons to carbon.
Initial analysis of the 13C and multiplicity-edited HSQC spectra revealed 19 protonated
carbons; four methyls (δC 16.16; 16.20; 17.9, 25.9), seven methylenes (δC 24.7; 26.7;
26.88; 26.89; 34.8; 39.8; 39.9), six olefinic methines (δC 118.9; 123.0; 124.1; 124.5,
147.7; 194.9), two oxymethines (δC 67.0; 97.8), leaving six non-protonated carbons
(δC 131.6; 135.4; 136.8; 146.1; 170.3, 170.3). The quaternary carbon resonance at
δC 170.3 is characteristic of an α,β-unsaturated lactone or acid. A highly deshielded
carbonyl methine (δH 9.41, δC 194.9) indicated the presence of an α,β-unsaturated
aldehyde. Four quaternary carbon resonances (δC 131.6, 135.4, 136.8, 146.1), together
with olefinic methines at δH 123.0, 124.1, 124.5, 147.7, are typical for four trisubstituted
olefins. With five double bonds accounted for, this requires that the molecule be
monocyclic.
HMBC correlations observed from two of the methyl singlets CH3-20 (δH 1.68; δC 25.9)
and CH3-21 (δH 1.60; δC 17.9) to the same two carbons; olefinic methine carbon
CH-18 (δH 5.08; δC 124.5) and quaternary olefinic carbon C-19 (δC 131.6) as well
as to each other implied the presence of geminal methyls as part of a trisubstituted
double bond. Long-range COSY correlations from H-18 to H3-20, in conjunction with
HMBC correlations from H-18 to CH3-20 and CH3-21, confirmed this connectivity.
HMBC correlations from H-18 to methylene carbon CH2-17 (δH 2.05; δC 26.9) and
a COSY correlation between H2-18 and H2-17 extended the fragment further, unveiling
substructure A (Figure 6.2) as an isoprene unit.
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18
17
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COSY
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Figure 6.2. COSY and HMBC correlations establishing connectivity of the terminal
isoprene unit, substructure A, of secothorectolide (49).
COSY and HMBC correlations between CH2-17 and methylene CH2-16 (δH 1.96;
δC 39.9), established the connectivity between the two respective carbons. Further
HMBC correlations were observed from H2-16 to an olefinic quaternary carbon C-15
(δC 135.4), olefinic methine carbon CH-14 (δH 5.08; δC 124.1) and methyl carbon CH3-
22 (δH 1.59; δC 16.2), suggesting the presence of another trisubstituted double bond.
HMBC correlations from H3-22 to C-16, C-15 and C-14 (δH 5.08; δC 124.1), together
with COSY correlations between H3-22 and H-14 confirmed this connection.
Two further methylenes CH2-13 (δH 2.05; δC 26.9) and CH2-12 (δC 39.8, δH 1.96)
were placed next to the double bond based on COSY and HMBC correlations observed
between CH-14, CH2-13 and H2-12. CH2-12 showed further HMBC correlations to
13C
resonances attributed to another trisubstituted double bond— C-11 (δC 136.8), olefinic
methine CH-10 (δH 5.10; δC 123.0) and an attached methyl, CH3-23 (δH 1.57; δC 16.2).
COSY and HMBC correlations from H-10 and H2-9 (δH 2.05; δC 26.9) extended the
fragment further, unveiling substructure B (Figure 6.3) as two unfunctionalised isoprene
units.
CH3
H
16
22
17
14
HMBC
COSY
CH3
H
11
23
13 9
Figure 6.3. COSY and HMBC correlations establishing connectivity of the isoprene
units, substructure B, of secothorectolide (49).
COSY correlations were observed from H2-9 to methylene proton H2-8 (δH 2.30; δC 24.7)
that established two contiguous methylenes, confirmed through HMBC correlations from
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H2-9 to C-8 and H2-8 to C-9. Further HMBC correlations from H2-8 to an olefinic
quaternary carbon C-7 (δC 146.1) and olefinic methine carbon CH-6 (δH 6.55; δC 147.7)
revealed another trisubstituted double dond. CH-6 has an unusual, highly deshielded
chemical shifts compared to the two previous trisubstituted double bonds. The H-6 proton
appeared at δH 6.55 ppm while its carbon C-6 resonated at δC 147.7 ppm and the C-
7 carbon resonance appeared at δC 146.1. With all four methyls accounted for, this
trisubstituted double bond was considered to have a different chemical environment. The
H2-8 proton showed an extra HMBC correlation to the aldehyde carbon C-24 (δH 9.41;
δC 194.9). The aldehyde proton H-24 showed HMBC correlations to three carbons, C-
7, C-6, and C-8, establishing its connection to the polarised trisubstituted double bond.
Further analysis of the COSY spectrum revealed a long-range correlation between H-6
and H2-8, together with HMBC correlations from H-6 to C-24 and C-7, and confirmed
the connectivity of the trisubstituted double bond (Figure 6.5). The deshielding effect on
aldehyde carbon C-24 was consistent with the presence of a conjugated double bond (C-6
and C-7). In addition, the stereochemistry of the double bond ∆6,7 was assigned as E,
based on the chemical shift of the aldehyde proton, δH 9.41 ppm, corresponding to the
slightly shielded values recognised for the E configuration (E: 9.3–9.4 ppm; Z: 10.0–10.1
ppm) of this functional group.118,131,153
H
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CH3
H
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23
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10
Figure 6.4. COSY and HMBC correlations establishing connectivity of the isopropene
unit, substructure C, of secothorectolide (49).
Further analysis of the HMBC spectrum showed extra correlations from H-6 to methylene
CH2-5 (δH 2.81, 2.86; δC 34.8) and oxymethine carbon CH-4 (δH 4.82; δC 67.0),
assigning a methylene carbon CH2-5 between the polarised double bond (C-6 and C-7),
and the oxymethine CH-4. The difference in chemical shift of the two protons of this
methylene CH2-5 is consistent with an adjacent chiral centre (CH-4). HMBC correlations
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from the H2-5 protons to C-7, C-6 and C-4 are consistent with this assignment. In the
coupled HSQC spectrum, the oxymethine CH-4 has 1JCH of 147 Hz which is typical for
that of a sp3 carbon attached to oxygen. COSY correlations were observed from H2-5
to H-4 and H-6 that confirmed this skeletal arrangement. This connectivity was further
supported by the triplet signal observed in the 1H NMR spectrum for olefinic methine
proton H-6 which indicated a methylene proton CH2-5 adjacent.
With 21 of the 25 carbons and 33 of the 36 protons accounted for, a fragment containing
four carbons, three oxygens, three hydrogens including an exchangeable proton, remained
to be assigned (C4H3O3). The chemical shift of the C-1 (δC 170.3) carbonyl was
typical of an α,β-unsaturated lactone. Also supporting this assumption was the fact
that five of the double bond eqiuvalents were accounted for, leaving three double bond
equivalents. These requirements are consistent with that of a butenolide ring system.
The oxymethine proton H-4 showed weak HMBC correlations to three carbons, C-6, C-2
(δH 6.11; δC 118.9), and C-5. The olefinic methine proton H-2 also showed HMBC
correlations to C-1 (δC 170.3), C-25 (δH 6.18; δC 97.8), and C-4. Weak COSY
correlations between H-2 and H-4 but not between H-25 and H2-4 (in the case of 46
and 47) was observed, which suggested a β-substituted-γ-hydroxybutenolide. With aid
from the literature, the ring system was assigned as a β-substituted-γ-hydroxybutenolide
ring, which is also encountered in luffariellolide,108 luffariolides,110,130 manoalide,117,119
luffariellins,118,131 cacospongiolides,122,123 fasciospongides,126 and sarcotins.154 In addi-
tion, the E-configuration of the C-6–C-7 prevents ring closure between the C-24 aldehyde
and the hydroxyl group at C-4 which lead to the formation of thorectolide (48). Therefore
the structure of secothorectolide is given as 49 with NMR data presented in Table 6.2.
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Figure 6.5. COSY and HMBC correlations establishing connectivity of the isopropene
unit, substructure D, of secothorectolide (49).
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6.4 Biological Activity
The biological activity profile of thorectolide (48) and secothorectolide (49) against
human cancer cell lines has undergone preliminary investigation. An MTT assay on
ovarian cancer (1A9) cells was performed at the School of Biological Sciences, VUW.
Compounds 48 and 49 were found to be moderately cytotoxic with IC50 values of 3.74
and 2.45 µM respectively.86
6.5 Related Compounds
Two isomeric linear sesterterpenes (152 and 153) were isolated from the Caribbean
sponge Thorecta horridus.155 Compound 152 shown a marked inflammatory activity,
inducing the release of histamine and causing oedema in the paw of test animals. Luffarins
A-Z have been reported from the Australian marine sponge Luffariella geometrica and
they are classified into 14 bicyclic sesterterpenes based on their chemical structures;118
luffarins A-N; one bicyclic bisnorsesterterpene, luffarin O; one monocyclic sesterterpene,
luffarin P; and six acyclic sesterterpenes, luffarins Q-V (152–158), in addition to four
diterpenoidal derivatives, luffarin W-Z. Luffarin Q and compound 152, have similar
structures and both compounds were reported to have E geometry for the three double
bonds. For this reason, it was suggested that 152 and luffarin Q are the same compound.
Luffarin T (156) is a dehydro analogue of luffarin S (155) while luffarin V (158) is
a dihdro analogue of both luffarins T and U (156 and 157). Cacospongionolide D
(159) and (6Z)-luffarin V (160) were isolated from the marine sponge Fasciospongia
cavernosa from the Bay of Naples.155 Despite the structural relationship with luffarins,
cacospongionolide D (159) exhibited significant cytotoxicity.156 This notion suggested
a possible relation between the presence of the α-hydroxybutenolide moiety and the
cytotoxicity.
A new sesterterpene (161), related to luffarins, has been isolated from the sponge
Fasciospongia cavernosa from the Adriatic Sea.129 The absolute stereochemistry of 161
was determined by application of Mosher’s method. Fasciospongides B and C (162 and
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163) were obtained from the New Caledonian sponge Fasciospongia sp.126 Compounds
162 and 163 possess a new oxidized variant of the cyclohexenyl ring found in manoalide
(109) and other analogues. Thorectolide monoacetate (164) was first obtained from the
marine sponge Thorectandra excavatus.124 The absolute configuration of C-24 and C-4
were assigned following re-isolation of 164 from a New Caledonian marine sponge of
the genus Hyrtios, together with thorectolide (48).120 The hydroxyl group at C-24 was
established as axial and the absolute configuration of C-4 was assigned as R by measuring
the Cotton Effect of the diol, obtained by reduction of 164.
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6.5.1 Biosynthetic relationship between all Luffarella metabolites
Biosynthetically, a relationship could be recognized between the various luffarins as
illustrated in Scheme 6.2. Luffarins appear to belong to the same enantiomeric series as
reported for manoalide-type marine natural products. It is also curious to note that none
of the acyclic luffarins incorporated the hydroxylated butenolide functionality. Perhaps
the most interesting luffarins from a biosynthetic point of view are luffarins B (165)
and O (166), which were the first examples of a hitherto unknown cyclization pattern
in compounds of this class.118 The E-configuration of the C-6–C-7 in secothorectolide
(49) prevents ring closure between the C-24 aldehyde and the hydroxyl group at C-4 that
lead to the formation of thorectolide (48), as illustrated in pathway C (Scheme 6.2).
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Scheme 6.2. Postulated biosynthetic relationship between all known Luffariella
metabolites.118
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Chapter 7
Conclusion
Marine biomedicine is one of the most recent focal points in assessing the role of the
oceans in human health. There is simply no question that the vast diversity of plants and
animals in the sea will contribute toward the amelioration of human suffering.
Marine sponges do not have physical means of defense and so have developed a rich
chemical arsenal that can be exploited in the search for new pharmaceutical leads. Not
suprisingly, marine sponges are still the most prolific producers of biologically active
marine natural products.
Over the course of this study, various species of Tongan marine sponge were examined
using an NMR-based screening method, in order to identify which sponge extracts were
worthy of further investigation. The isolation of metabolites from selected sponges was
then guided by NMR analysis, which led to isolation of three new chemical structures
from two different species, together with 11 known compounds.
The two novel sesterterpenes, isoluffariellolide (46) and 1-O-methylisoluffariellolide
(47) share the same backbone pattern as the known luffariellolide (45) and 25-O-
methylluffariellolide (107) respectively, and differ only in the substitution on the buteno-
lide ring. In the literature, the majority of the secondary metabolites that have the
butenolide ring are β-substituted with only few α-substituted (in the case of 46 and 47).
Isoluffariellolide (46) was found to be approximately six times less cytotoxic than 1-O-
methylisoluffariellolide (47). Interestingly, these results suggested that the 1-O-methyl
group in compound 47 plays an important role in the cytotoxicity of the compound.
Secothorectolide (49) is a ring-opened and geometric isomer of the known compound
thorectolide (48). This ring closure and opening relationship was also observed between
manoalide (109) and secomanoalide (110), as well as luffariellins A (141) and B (142).
Despite the different carbon skeleton, the functional groups in 141 and 142 are similar
with those in 109 and 110, respectively, and not surprisingly the biological properties are
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almost identical. The biological activities of compounds 48 and 49 were almost the same,
which would give an insight into the structure-activity relationship (SAR) between these
types of compounds.
In addition, the structurally related known bromotyrosines (52–54) and pyrroloquinoline
metabolites (55–56) isolated in this research can be tested in screening libraries, that
are unbiased by specific biological activity (as in bioassay guided studies), in order to
understand their SAR and mode of action.
In New Zealand sponges, primary metabolites dominate the 75% Me2CO/H2O fraction
(the mass window). Even though most primary metabolites were discarded in both
the 30% Me2CO/H2O and 100% Me2CO fractions, the levels of secondary metabolites
were very low. The screening technique was adapted to find the approximately one in
ten sponges that contained enough secondary metabolites to detect. Using this general
methodology on tropical sponges we found that the 75% Me2CO/H2O was predominantly
secondary metabolites in every sponge examined. The problem was not finding secondary
metabolites, but finding novel compounds. While some of the techniques developed in
this study have helped find novel compounds, more sophisticated methods will have to be
developed to rapidly identify well known secondary metabolites and detect the presence
of novel compounds.
Furthermore, sponges that are abundant in Tongan waters have been investigated before by
other marine natural groups (collected from Fiji, Vanuatu, Papua New Guinea, Solomon
Islands, etc.). Not surprisingly, their chemical content is quite similar to that from Tongan
sponges. From our experience from these collecting trips, the less abundant sponges
(which might be ignored by other research groups) tend to have higher probablility
of containing novel secondary metabolites. Therefore, on future collecting trips, these
sponges can be targeted, and with the Tongan sponges proved to have higher secondary
metabolites content compared to New Zealand sponges, isolation of novel compounds
from smaller amount of sponges can be achieved using the VUW screening method.
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Chapter 8
Experimental
8.1 General Experimental
NMR spectra were obtained using a Varian Direct Drive spectrometer equipped with
a triple resonance HCN cryogenic probe, operating at 600 MHz for the 1H nucleus,
150 MHz for the 13C nucleus and 60 MHz for 15N nucleus. All HSQC spectra were
obtained as coupled HSQC. Chemical shifts δ(ppm) were internally referenced to the
residual solvent peak.157 For acid sensitive compounds, a catalytic amount(1-2 µL) of
d5-pyridine is added to each NMR sample performed in CDCl3 to prevent compound
degradation due to acidity associated with the solvent. 1H NMR quantification of samples
was performed with an internal CH3NO2 standard (100 µL in 5 mL CDCl3), using the
acquisition parameters described by West.52 High-resolution mass spectra were obtained
using a Micromass Q-TOF Premier mass spectrometer. TLC analyses were performed on
Machery-Nagel Alugram SIL G/UV254 normal-phase silica plates using a mobile phase
of 5% MeOH/CH2Cl2 unless otherwise stated. The TLC plates were visualised by either
(1) fluorescence quenching under UV light (λ = 254 nm), (2) fluorescence under UV light
(λ = 350 nm), (3) dipping in 5% H2SO4 (conc.)/MeOH solution, followed by dipping in a
solution of 0.1% vanillin in EtOH (% wt/vol) then heating, or a combination of the above.
Normal-phase column chromatography was performed using YMC Co. LTD 2,3-
dihydropropoxypropyl-derivatised silica (DIOL), or silica (SiO2). Reversed-phase col-
umn chromatography was carried out using Supelco Diaion HP20 or HP20SS poly(styrene
divinylbenzene) (PSDVB) resin. All solvents used in bench-top chromatography were
glass-distilled. All other reagents were purchased commercially (at least reagent grade)
and distilled prior to use when necessary. High-pressure liquid chromatography (HPLC)
was performed using a Rainin Dynamax SD-200 solvent delivery module with 25 mL
pump heads (analytical scale), or a Varian PrepStar 210 solvent delivery module with 100
mL pump heads (preparative and semi-preparative scale). UV detection for HPLC runs
94
was obtained with a Varian Prostar 335 photodiode array detector. All organic solvents
used were HPLC grade and H2O was glass-distilled and deionised using a MilliQ system.
Solvent mixtures are reported as % vol/vol, unless otherwise stated.
8.2 Investigation of Genus Fascaplysinopsis
8.2.1 Initial Fractionation of Fascaplysinopsis sp.
The sponge (PTN3 19A and PTN3 22B) was collected by hand using SCUBA from an
underwater cave at the southwest of Eua, Tonga in late November 2008. The sample was
frozen immediately and kept at -18 ◦C until extraction. Voucher samples (PTN3 19A and
PTN3 22B) have been deposited and stored in 100% EtOH, at the School of Chemical
and Physical Sciences, Victoria University of Wellington, New Zealand.
The sponge (200 g frozen weight) was cut into small pieces and extracted with MeOH (2
× 1 L each) for 24 hours. The second then first methanolic extracts were cylic loaded∗
onto a glass column packed with HP20 beads (200 mL) pre-equilibrated in MeOH. The
combined eluent was then diluted with H2O (2 L) and passed through the same column.
This eluent was further diluted with H2O (4 L) and passed again through the same column.
The loaded column was then washed with 600 mL of H2O and fractionated with 600 mL
of increasing concentrations of Me2CO in H2O; (i) 30% (fraction A), (ii) 40% (fraction
B), (iii) 60% (fraction C), (iv) 80% (fraction D), (v) 100% Me2CO (fraction E). Fractions
A to D were each individually back-loaded onto glass columns packed with HP20 beads
(80 mL) pre-equilibrated in MeOH. The columns were then washed with H2O (240 mL)
and eluted with Me2CO (240 mL). The eluents were then concentrated to dryness to give
149.1 mg of fraction A, 92.9 mg of fraction B, 379.8 mg of fraction C and 648.9 mg of
fraction D. Fraction E was also concentrated to dryness (614.7 mg).
∗For a detailed discussion of cyclic loading and back loading, please see Chapter 2, Section 2.1.1.
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8.2.2 Isolation of Homofascaplysin A
Fraction A (∼96.1 mg) was dissolved in 2 mL HPLC grade MeOH. The sample was then
injected onto a semi-preparative (250 mm × 10 mm) C18 HPLC column pre-equilibrated
with 50% MeCN/0.5M HCOOH(aq), with a flow rate of 5 mL/min and UV detection set
to λ245nm and λ280nm. The column was then eluted with 50% MeOH/0.1M HCOOH(aq).
The fractions eluted between 1.5–2.0 minutes (fraction F), 2.2-3.3 minutes (fraction G)
were collected. Fraction F was back-loaded onto a 3 mL HP20SS column. The column
was eluted with 15 mL of Me2CO and then concentrated to dryness.
1H NMR analysis
showed that fraction F contained 13.7 mg homofascaplysin A. Fraction G was back-
loaded onto a 3 mL HP20SS column. The column was eluted with 15 mL of Me2CO
and then concentrated to dryness. 1H NMR analysis showed that fraction G contained
10.8 mg of homofascaplysin A. Fraction F and G were combined to yield 24.5 mg of
homofascaplysin A (43).
Homofascaplysin A (43)
Amphorphous yellow solid; all spectroscopic data as previously published.91
8.2.3 Isolation of Luffariellolide, Isoluffariellolide, 1-O-Methylisoluffa-
riellolide
Fraction D (∼336 mg) was dissolved in a minimum amount of CH2Cl2 and loaded
onto a glass column packed with silica gel (60 mL) pre-equilibrated in CH2Cl2.
The loaded column was then eluted with 100 mL portions of: (i) 100% CH2Cl2,
(ii) 5% EtOAc/CH2Cl2, (iii) 15% EtOAc/CH2Cl2, (iv) 30% EtOAc/CH2Cl2, (v) 50%
EtOAc/CH2Cl2, (vi) 100% EtOAc, all fractions were collected across 129 test-tubes and
were concentrated to dryness. The fractions were analysed by TLC and fractions 8-16
were combined to give fraction H (9 mg) and fractions 37-46 were combined to give
fraction I (75.7 mg). 1H NMR analysis showed that fraction H contained impure 1-O-
methylisoluffariellolide, while fraction I revealed three structurally related compounds.
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Fraction H (9 mg) was dissolved in a minimum amount of pet. ether and loaded onto a
glass column packed with silica gel (10 mL) pre-equilibrated in pet. ether. The loaded
column was then eluted with 30 mL portions of; (i) 100% pet. ether, (ii) 5% CH2Cl2/pet.
ether, (iii) 10% CH2Cl2/pet. ether, (iv) 15% CH2Cl2/pet. ether, (v) 20% CH2Cl2/pet.
ether, (vi) 25% CH2Cl2/pet. ether, (vii) 30% CH2Cl2/pet. ether, (viii) 50% CH2Cl2/pet.
ether, (ix) 70% CH2Cl2/pet. ether, (x) 100% CH2Cl2, all fractions were collected across
48 test-tubes and were concentrated to dryness. The fractions were analysed by TLC and
fractions 33–36 (fraction J) were combined. 1H NMR analysis showed that fraction J
contained 0.2 mg of 1-O-methylisoluffariellolide (47).
Fraction I (∼10 mg) was dissolved in 300 µL of HPLC grade MeOH. Fifteen 20 µL
samples were then injected onto an analytical (250 mm × 4.6 mm) C18 HPLC column
pre-equilibrated with 95% MeCN/H2O, with a flow rate of 1 mL/min and UV detection
set to λ245nm and λ280nm. The eluent between 4.7-5.0 minutes (fraction K) was collected
and then concentrated to dryness. 1H NMR analysis showed that fraction K contained
1.2 mg of isodehydroluffariellolide (44). The eluent between 8.2-8.8 minutes (fraction
L) was collected and concentrated to dryness. 1H NMR analysis showed that fraction L
contained 3.3 mg mixture of isoluffariellolide (46) and accompanied by small amount of
luffariellolide (45).
Isodehydroluffariellolide (44)
Colourless oily residue; all spectroscopic data as previously published.91
Luffariellolide (45)
Yellowish oily residue; all spectroscopic data as previously published.108
Isoluffariellolide (46)
Yellowish oily residue; NMR data see Table 5.3; HRESIMS, observed m/z 409.3471
[M + Na]+, C25H38O3Na requires 409.2719, ∆ 0.0752 ppm.
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1-O-Methylisoluffariellolide (47)
Yellowish oily residue; NMR data see Table 5.5; HRESIMS, observed m/z 423.2867
[M + Na]+, C26H40O3Na requires 423.2875, ∆ 0.0008 ppm.
8.3 Investigation of Dictyoceratid Sponge
8.3.1 Isolation of Secothorectolide and Thorectolide
The sponge (PTN3 21C) was collected by hand using SCUBA from an underwater cave at
the southwest of ‘Eua, Tonga in late November 2008. The sample was frozen immediately
and kept at –18 ◦C until extraction. Voucher sample (PTN3 21C) has been deposited
and stored in 100% EtOH, at the School of Chemical and Physical Sciences, Victoria
University of Wellington, New Zealand.
The sponge (26 g frozen weight) was cut into small pieces and extracted with MeOH
(2 × 100 mL each) for 24 hours. The second then first methanolic extracts were cyclic
loaded onto a glass coloumn packed with HP20 beads (25 mL) pre-equilibrated in MeOH.
The combined eluent was then diluted with H2O (200 mL) and passed through the same
column. This eluent was further diluted with H2O (400 mL) and passed through the
column. The column was then washed with 75 mL of H2O. The loaded column was eluted
with 75 mL of increasing concentrations of Me2CO in H2O: (i) 30% (fraction A), (ii) 75%
(fraction B) and (iii) 100% Me2CO (fraction C). Fractions A and B were each individually
back-loaded onto glass columns packed HP20 beads (75 mL) pre-equilibrated in MeOH.
The columns were then washed with H2O (75 mL) and eluted with Me2CO (75 mL). The
eluents were then concentrated to dryness to give 20 mg of fraction A, 61.9 mg of fraction
B. Fraction C was also concentrated to dryness (63.7 mg).
The TLC and NMR examination of the resulting fractions showed that the interesting
signals were confined to the 75% Me2CO/H2O fraction. Fraction B (∼41.9 mg) was
dissolved in 1.5 mL of HPLC grade MeOH. Fifteen 100 µL samples were then injected
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into a semi-preparative (250 mm × 10 mm) C18 HPLC column pre-equilibrated with
85% MeCN/H2O, with a flow rate of 4 mL/min and UV detection set to λ245nm and
λ280nm. The eluent between 7.6-8.6 minutes (fraction D) and 11.3–12.3 minutes (fraction
E) was collected and then concentrated to dryness. 1H NMR analysis showed that
fraction D contained 3.9 mg of secothorectolide and fraction E contained 3.7 mg impure
thorectolide.
Fraction D (3.9 mg) was dissolved in 140 µL of HPLC grade MeOH. Seven 20 µL
samples were then injected onto an analytical (250 mm × 4.6 mm) C18 HPLC column
pre-equilibrated with 85% MeCN/H2O, with a flow rate of 1 mL/min and UV detection
set to λ245nm and λ280nm. The eluent between 6.6-7.6 minutes (fraction F) was collected
and then concentrated to dryness. 1H NMR analysis showed that fraction F contained 2.7
mg of secothorectolide (49).
Fraction E (3.7 mg) was dissolved in 140 µL of HPLC grade MeOH. Seven 20 µL
samples were then injected onto an analytical (250 mm x 4.6 mm) C18 HPLC column
pre-equilibrated with 85% MeCN/H2O, with a flow rate of 1 mL/min and UV detection
set to λ245nm and λ280nm. The eluent between 9.3-9.9 minutes (fraction G) was collected
and then concentrated to dryness. 1H NMR analysis showed that fraction G contained 1.6
mg of thorectolide (48).
Thorectolide (48)
Colourless oily residue; all spectroscopic data as previously published.120
Secothorectolide (49).
Colourless oily residue; NMR data see Table 6.2; HRESIMS, observed m/z 439.2460
[M + Na]+, C25H36O5Na requires 439.2460, ∆ 0.0 ppm.
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8.4 Investigation of a Verongiid Sponge
8.4.1 Isolation of Aplysamine-2 and Aerophobin-1
The sponge (PTN3 33F) was collected by snorkel from Ano Beach, Vava‘u, Tonga in
late November 2009. The sample was frozen immediately and kept at –18 ◦C until
extraction. A voucher sample (PTN3 33F) has been deposited and stored in 100% EtOH,
at the School of Chemical and Physical Sciences, Victoria University of Wellington, New
Zealand.
The sponge (27 g wet weight) was cut into small pieces and extracted with MeOH (2 x
100 mL each) for 24 hours. The second then first methanolic extracts were loaded onto a
glass column packed with HP20 beads (30 mL) pre-equilibrated in MeOH. The combined
eluent was then diluted with H2O (200 mL) and passed through the same column. This
eluent was further diluted with H2O (400 mL) and passed again through the same column.
The loaded column was then washed with 120 mL of H2O and fractionated with 120 mL
of increasing concentrations of Me2CO in H2O: (i) 30% (fraction A), (ii) 75% (fraction B)
and (iii) 100% (fraction C). Fractions A and B were each individually back loaded onto
glass columns packed with HP20 beads (30 mL) pre-equilibrated in MeOH. The columns
were then washed with H2O (120 mL) and eluted with Me2CO (120 mL). The eluents
were then concentrated to dryness to give 80.6 mg of fraction A, 86.7 mg of fraction B.
Fraction C was also concentrated to dryness (75.8 mg).
Fraction B (∼34.4 mg) dissolved in 10 mL of MeOH and cyclic loaded onto a glass
analytical column packed with 5 mL HP20SS pre-equilibrated in MeOH. The loaded
column was eluted with 30 mL of increasing concentrations of Me2CO in H2O: (i) 30%,
(ii) 40%, (iii) 50%, (iv) 60%, (v) 80% (fraction D) and (vi) 100%. NMR examination
of the eluted fractions showed that fraction D contained impure aplysamine-2 (9.7 mg).
Fraction D was dissolved in a minimum amount of pet. ether and loaded onto a glass
column packed with DIOL (10 mL) pre-equilibrated in pet. ether. The loaded column
was then eluted with 30 mL portions of; (i) 100% pet. ether (ii) 50% CH2Cl2/pet.
ether, (iii) 75% CH2Cl2/pet. ether, (iv) 100% CH2Cl2, (v) 5% EtOAc/CH2Cl2, (vi) 15%
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EtOAc/CH2Cl2, (vii) 30% EtOAc/CH2Cl2, (viii) 50% EtOAc/CH2Cl2, (ix) 100% EtOAc,
(x) 100% MeOH. All fractions were collected across 41 test-tubes, and based on TLC
examination, test-tubes 39–41 were combined to give 5.1 mg of impure aplysamine-2
(fraction E). Fraction E (5.1 mg) was dissolved in 300 µL of HPLC grade MeOH. Ten 30
µL samples were then injected onto an analytical (250 mm× 4.6 mm) C18 HPLC column
pre-equilibrated with 85% MeCN/H2O, with a flow rate of 1 mL/min and UV detection
set to λ245nm and λ280nm. The eluent between 2.5-2.6 minutes (fraction F) was collected
and then concentrated to dryness. 1H NMR analysis showed that fraction F contained 0.6
mg of aplysamine-2 (50).
Fraction B (∼52.3 mg) was dissolved in a minimum amount of pet. ether and loaded
onto a glass column packed with DIOL (30 mL) pre-equilibrated in pet. ether. The
loaded column was then eluted with 50 mL portions of; (i) 100% pet. ether (ii) 100%
CH2Cl2, (iii) 50% EtOAc/CH2Cl2, (iv) 100% EtOAc, (v) 10% EtOAc/MeOH, (vi) 30%
EtOAc/MeOH, (vii) 50% EtOAc/MeOH, (viii) 100% MeOH. All fractions were collected
across 60 test-tubes. Based on NMR and TLC examination, test-tubes 46–52 were
combined to give 7.1 mg of impure aerophobin-1 (fraction G). Fraction G (7.1 mg) was
dissolved in 300 µL of HPLC grade MeOH. Ten 30 µL samples were then injected onto an
analytical (250 mm x 4.6 mm) C18 HPLC column pre-equilibrated with 85% MeCN/H2O,
with a flow rate of 1 mL/min and UV detection set to λ245nm and λ280nm. The eluent
between 2.0-2.7 minutes (fraction H) was collected and then concentrated to dryness. 1H
NMR analysis showed that fraction G contained 1.2 mg of aerophobin-1 (51).
Aplysamine-2 (50)
A pale tan semicrystalline solid; all spectroscopic data as previously published.72
Aerophobin-1 (51)
A pale white semicrystalline solid; all spectroscopic data as previously published.73
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8.5 Investigation of Verongiid Sponge
8.5.1 Isolation of Fistularin-3, Aeroplysinin-1 and LL-PAA216
The sponge (PTN3 46E) was collected by hand using SCUBA from Tu‘ungasika Island,
Vava‘u, Tonga in late November 2009. The sample was frozen immediately and kept at
–18 ◦C until extraction. A voucher sample (PTN3 46E) has been deposited and stored
in 100% EtOH, at the School of Chemical and Physical Sciences, Victoria University of
Wellington, New Zealand.
The sponge (27 g wet weight) was cut into small pieces and extracted with MeOH (2 x 100
mL each) for 24 hours. The second then first methanolic extracts were loaded onto a glass
coloumn packed with HP20 beads (30 mL) pre-equilibrated in MeOH. The combined
eluent was then diluted with H2O (100 mL) and passed through the same column. This
eluent was further diluted with H2O (200 mL) and passed through the column. The
column was then washed with 75 mL of H2O. The loaded column was eluted with 120 mL
of increasing concentrations of Me2CO in H2O: (i) 30% (fraction A), (ii) 75% (fraction
B) and 100% (fraction C). Fractions A and B were each individually back loaded onto
glass columns packed with HP20 beads (30 mL) pre-equilibrated in MeOH. The columns
were then washed with H2O (120 mL) and eluted with Me2CO (120 mL). The eluents
were then concentrated to dryness to give 136 mg of fraction A, 726.5 mg of fraction B.
Fraction C was also concentrated to dryness (105.5 mg). TLC and NMR examination of
the resulting fractions showed that the interesting signals were confined to the 30% and
75% Me2CO/H2O fractions.
Fraction A (∼32.8 mg) was dissolved in a minimum amount of CH2Cl2 and loaded onto
a glass column packed with silica gel (10 mL) pre-equilibrated in CH2Cl2. The loaded
column was then eluted with 30 mL portions of; (i) 100% CH2Cl2, (ii) 5% EtOAc/CH2Cl2,
(iii) 15% EtOAc/CH2Cl2, (iv) 30% EtOAc/CH2Cl2, (v) 50% EtOAc/CH2Cl2, (vi) 100%
EtOAc, (vii) 5% MeOH/EtOAc, (viii) 15% MeOH/EtOAc, (ix) 30% MeOH/EtOAc, (x)
100% MeOH, all fractions were collected in 48 test-tubes and were concentrated to
dryness. The fractions were analysed by TLC and fractions 12–17 (fraction D) and
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fractions 28–33 (fraction E) were combined. 1H NMR analysis showed that fraction
D contained 8.6 mg of aeroplysinin-1 (53) and fraction E contained 6.2 mg LL-PAA216
(54).
Fraction B (∼57.9 mg) dissolved in 10 mL of MeOH and cyclic loaded onto a glass
analytical column packed with 5 ml HP20SS pre-equilibrated in MeOH. The loaded
column was eluted with 25 mL of increasing concentrations of Me2CO in H2O: (i) 30%
(fraction F) , (ii) 40% (fraction G), (iii) 50% , (iv) 60% (fraction H), (v) 80%, and (vi)
100%. All fractions were collected in test-tubes and were concentrated to dryness to give
5.3 mg of fraction F, 7.4 mg of fraction G, 3.3 mg (50% Me2CO/H2O fraction), 24.3 mg
of fraction H, 11.1 mg (80% Me2CO/H2O fraction) and 0.8 mg (fraction 100% Me2CO).
Fraction F (5.3 mg) was dissolved in a minimum amount of CH2Cl2 and loaded onto
a glass column packed with silica gel (10 mL) pre-equilibrated in CH2Cl2. The loaded
column was then eluted with 30 mL portions of; (i) 100% CH2Cl2, (ii) 5% EtOAc/CH2Cl2,
(iii) 15% EtOAc/CH2Cl2, (iv) 30% EtOAc/CH2Cl2, (v) 50% EtOAc/CH2Cl2, (vi) 75%
EtOAc/CH2Cl2, (vii) 100% EtOAc, (viii) 10% MeOH/EtOAc, (ix) 100% MeOH, all
fractions were collected across 42 test-tubes and were concentrated to dryness. The
fractions were analysed by TLC and fractions 13–17 (fraction I) and fractions 31–37
(fraction J) were combined. 1H NMR analysis showed that fraction I contained 2.2 mg of
aeroplysinin-1 and fraction J contained 1.8 mg of LL-PAA216 (54).
Fraction G (7.4 mg) was dissolved in a minimum amount of CH2Cl2 and loaded onto
a glass column packed with silica gel (10 mL) pre-equilibrated in CH2Cl2. The loaded
column was then eluted with 30 mL portions of; (i) 100% CH2Cl2, (ii) 5% EtOAc/CH2Cl2,
(iii) 15% EtOAc/CH2Cl2, (iv) 30% EtOAc/CH2Cl2, (v) 50% EtOAc/CH2Cl2, (vi) 100%
EtOAc, (vii) 5% MeOH/EtOAc, (viii) 10% MeOH/EtOAc, (ix) 100% MeOH, all fractions
were collected in 42 test-tubes and were concentrated to dryness. The fractions were
analysed by TLC and fractions 7–17 (fraction K) and 25–32 (fraction L) were combined.
1H NMR analysis showed that fraction K contained 0.7 mg of aeroplysinin-1 and fraction
L contained 0.8 mg of LL-PAA216.
Fraction H (24.3 mg) was dissolved in a minimum amount of CH2Cl2 and loaded onto
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a glass column packed with silica gel (10 mL) pre-equilibrated in CH2Cl2. The loaded
column was then eluted with 30 mL portions of; (i) 100% CH2Cl2, (ii) 5% EtOAc/CH2Cl2,
(iii) 10% EtOAc/CH2Cl2, (iv) 15% EtOAc/CH2Cl2, (v) 30% EtOAc/CH2Cl2, (vi) 50%
EtOAc/CH2Cl2, (vii) 100% EtOAc, (viii) 5% MeOH/EtOAc, (ix) 100% MeOH, all
fractions were collected across 43 test-tubes and were concentrated to dryness. The
fractions were analysed by TLC and fractions 26–31 (fraction M) were combined. 1H
NMR analysis showed that fraction M contained 18 mg of fistularin-3 (52). Fractions D,
I, and K were combined to yield 11.5 mg of aeroplysinin-1 (53) and fractions E, J, and L
were combined to give 8.8 mg of LL-PAA216 (54).
Fistularin-3 (52)
Colourless solid; all spectroscopic data as previously published.64
Aeroplysinin-1 (53)
Colourless solid; all spectroscopic data as previously published.74
LL-PAA216 (54)
Colourless solid; all spectroscopic data as previously published.75
8.6 Investigation of a Poecilosclerid Sponge
8.6.1 Isolation of of Makaluvamine G and Prianosin B
Unidentified black sponge (PTN4 10A), was collected by hand using SCUBA from
Fakafotula¯, Vava‘u, Tonga in late November 2009. The sample was frozen immediately
and kept at -18 ◦C until extraction. A voucher sample (PTN4 10A) has been deposited
and stored in 100% EtOH, at the School of Chemical and Physical Sciences, Victoria
University of Wellington, New Zealand.
The sponge (21 g wet weight) was cut into small pieces and extracted with MeOH (2 ×
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100 mL each) for 24 hours. The second then first methanolic extracts were loaded onto a
glass column packed with HP20 beads (30 mL) pre-equilibrated in MeOH. The combined
eluent was then diluted with H2O (200 mL) and passed through the same column. This
eluent was further diluted with H2O (400 mL) and passed through the column. The
column was then washed with 100 mL of H2O. The loaded column was eluted with
100 mL of increasing concentrations of Me2CO in H2O: (i) 30% (fraction A), (ii) 75%
(fraction B) and (iii) 100% (fraction C). Fraction A and B were each individually back-
loaded onto glass columns packed HP20 beads (30 mL) pre-equilibrated in MeOH. The
columns were then washed with H2O (100 mL) and eluted with Me2CO (100 mL). The
eluents were then concentrated to dryness to give 90.6 mg of fraction A, 68 mg of fraction
B. Fraction C was also concentrated to dryness (60.8 mg). TLC and NMR examination
of the resulting fractions showed that the interesting signals were confined to the 75%
Me2CO in H2O fraction.
Fraction B (∼17.9 mg) was dissolved in 10 mL of MeOH and cyclic loaded onto a glass
analytical column packed with 5 mL HP20SS pre-equilibrated in MeOH. The loaded
column was eluted with 30 mL of increasing concentrations of MeOH in H2O: (i) 30%,
(ii) 40%, (iii) 50% , (iv) 60%, (v) 80% and (vi) 100%. All fractions were concentrated
to dryness and based on TLC, the 80% MeOH/H2O and 100% MeOH fractions were
combined to give 9.2 mg (fraction D). Fraction D was dissolved in a minimum amount of
CH2Cl2 and loaded onto a glass column packed with DIOL (10 mL) pre-equilibrated in
CH2Cl2. The loaded column was then eluted with 30 mL portions of; (i) 100% CH2Cl2,
(ii) 5% EtOAc/CH2Cl2, (iii) 10% EtOAc/CH2Cl2, (iv) 15% EtOAc/CH2Cl2, (v) 30%
EtOAc/CH2Cl2, (vi) 50% EtOAc/CH2Cl2, (vii) 100% EtOAc, (viii) 5% EtOAc/MeOH,
(ix) 30% EtOAc/MeOH, (x) 50% EtOAc/MeOH, (xi) 100% MeOH. All fractions were
collected across 60 test-tubes. The fractions were analysed by TLC and fractions 45–56
(fraction E) were combined. NMR analysis showed that fraction D contained impure 3.8
mg of makaluvamine G. Fraction E (3.8 mg) was dissolved in 300 µL of HPLC grade
MeOH. Ten 30 µL samples were then injected onto a analytical (250 mm× 4.6 mm) C18
HPLC column pre-equilibrated with 85% MeCN/H2O, with a flow rate of 1 mL/min and
UV detection set to λ245nm and λ280nm. The eluent between 4.3-4.7 minutes (fraction F)
was collected and then concentrated to dryness. 1H NMR analysis showed that fraction F
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contained 0.8 mg of makaluvamine G (55).
Fraction B (∼50 mg) was dissolved in a minimum amount of CH2Cl2 and loaded onto a
glass column packed with DIOL (30 mL) pre-equilibrated in CH2Cl2. The loaded column
was then eluted with 50 mL portions of; (i) 100% CH2Cl2, (ii) 50% EtOAc/CH2Cl2, (iii)
75% EtOAc/CH2Cl2, (iv) 100% EtOAc, (v) 10% MeOH/EtOAc, (vi) 20% MeOH/EtOAc,
(vii) 40% MeOH/EtOAc, (viii) 60% MeOH/EtOAc, (ix) 80% MeOH/EtOAc, (x) 100%
MeOH, all fractions were collected across 78 test-tubes and were concentrated to dryness.
The fractions were analysed by TLC and fractions 21–22 (fraction G) were combined.
NMR analysis showed that fraction G contained 0.6 mg of prianosin B (56).
Makaluvamine G (55)
Greenish-black solid; all spectroscopic data as previously published.79
Prianosin B (56)
Red crystalline solid; all spectroscopic data as previously published.82
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Appendix A
Existing Marine Chemistry Sponge Screening Protocol
Preparation
Equipment Needed (per Screen)
• 1 x Screen column loaded with 80 mL of HP20 equilibrated in distilled MeOH
• 1 x Backloading column loaded with 40 mL of HP20 equilibrated in distilled MeOH
NMR Standard Preparation
Prepare a standard of 1,3,5-tribromobenzene in CDCl3 by dissolving 78.9 mg of 1,3,5-
tribromobenzene in 5 mL of CDCl3.
Procedure
1. Voucher Sample Preparation
• Take a voucher specimen of ca. 10 g of sponge material ensuring that both the
ectoderm and the endoderm are represented.
• Label and store the voucher sample in 75% IPA in H2O.
2. Extraction
• Extract ca. 100 g of sponge material in 400 mL of distilled MeOH overnight.
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• Filter the first extract and set aside. Re-extract the sponge material (and any filter
paper/celite as necessary) in 400 mL of distilled MeOH overnight.
• Filter the second extract.
• Keep all sponge material (and any filter paper/celite as necessary) until the screen
is complete at which time it may be discarded.
3. Cyclic Loading
• Pass the second extract through the screen column with a flow rate of ca. 10
mL/min.
• Pass the first extract through the screen column with a flow rate of ca. 10 mL/min.
Combine the eluent with that of the second extract.
• Dilute the combined eluents with 800 mL of distilled H2O. Pass the diluted eluents
back through the screen column at a flow rate of ca. 10 mL/min.
• Dilute the eluent with 1.6 L of distilled H2O. Pass the diluted eluent back through
the screen column at a flow rate of ca. 10 mL/min.
• The eluent should be kept until the screen is complete at which time it may be
discarded.
4. Elution
• Elute the screen column with 250 mL of distilled H2O at a flow rate of ca. 10
mL/min. The H2O eluent can be discarded immediately.
• Elute the screen column with 250 mL of 30% distilled Me2CO in distilled H2O (75
mL Me2CO to 175 mL H2O) at a flow rate of ca. 10 mL/min.
• Elute the screen column with 250 mL of 75% distilled Me2CO in distilled H2O
(187.5 mL Me2CO to 62.5 mL H2O) at a flow rate of ca. 10 mL/min.
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• Elute the screen column with 250 mL of distilled Me2CO at a flow rate of ca. 10
mL/min.
5. Backloading the 75% Acetone Fraction
• Dilute the 75% Me2CO fraction with 250 mL of distilled H2O. Pass the diluted
eluent through the backloading column at a flow rate of ca. 8 mL/min.
• Dilute the eluent with 500 mL of distilled H2O. Pass the diluted eluent back through
the backloading column at a flow rate of ca. 8 mL/min.
• The eluent should be kept until the screen is complete at which time it may be
discarded.
• Elute the backloading column with 150 mL of distilled Me2CO.
6. Processing the 75% Acetone Fraction
• Evaporate the Me2CO eluent of the backloading column to dryness and transfer to
a pre-weighed sample vial. Evaporate to dryness and record the mass.
• Sub-sample approximately 30 mg of material for NMR analysis if necessary.
• Prepare an NMR sample in ca. 700 µL of CD3OD in a 5 mm NMR tube.
• Add 10 µL of the 1,3,5-tribromobenzene standard (representing 507 nmol of 1,3,5-
tribromobenzene) to the NMR tube.
7. NMR Analysis of the 75% Acetone Fraction
• Run a 1H spectrum of the sample on the 600 MHz instrument using the standard
Screen1H parameter set. (Experiment time: ca. 4 min)
• Make a note Standard Added in the sample text.
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• Run a COSY spectrum of the sample using the standard ScreenCOSY parameter
set. (Experiment time: ca. 20 min)
• Run an HSQC spectrum of the sample using the standard ScreenHSQC parameter
set. (Experiment time: ca. 4 h)
• Process appropriately and export HSQC phasefile.
• Add HSQC phasefile to HSQC mask.
• Apply HSQC mask to HSQC phasefile.
8. Assigning Hit Values to the Screen
• Threshold set at 3%.
• Signal strength
– An arbitrary value indicating how the strength of the interesting peaks.
– Weak – 1. Medium – 2. Strong – 3 (remember to consider the subsampling
factor if necessary).
• Number of interesting peaks
-- Indicates how many red peaks in the HSQC. Something exhibiting more than
20 non-masked peaks will score a 10.
• Uniqueness of interesting peaks
– An arbitrary value indicating whether non-masked peaks represent something
interesting (1–10).
• Available mass
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– The total mass of the available sponge material (including that used for the
screen) in kg is multiplied by 10 and rounded to the nearest integer. If more than 1
kg of sponge material is available the score is 10.
• Recollectability
– Collected locally – 3. Collected from Northland – 2. Other – 1.
• Sum all 5 hit values. A score of 20 would be considered average.
9. Backloading the 30% Acetone Fraction
• Dilute the 30% Me2CO fraction with 250 mL of distilled H2O. Pass the diluted
eluent through the backloading column at a flow rate of ca. 8 mL/min.
• Dilute the eluent with 500 mL of distilled H2O. Pass the diluted eluent back through
the backloading column at a flow rate of ca. 8 mL/min.
• The eluent should be kept until the screen is complete at which time it may be
discarded.
• Elute the backloading column with 150 mL of distilled MeOH.
10. Processing the 30% Acetone Fraction
• Evaporate the MeOH eluent of the backloading column to dryness and transfer to a
pre-weighed sample vial. Evaporate to dryness and record the mass.
• Sub-sample approximately 30 mg of material for NMR analysis if necessary.
• Prepare an NMR sample in ca. µ700 L of CD3OD in a 5 mm NMR tube.
11. NMR Analysis of the 30% Acetone Fraction
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• Run a 1H spectrum of the sample on the 600 MHz instrument using the standard
Screen 1H parameter set. (Experiment time: ca. 4 min)
12. Processing the 100% Acetone Fraction
• Evaporate the Me2CO eluent of the screen column to dryness and transfer to a pre-
weighed sample vial. Evaporate to dryness and the record mass.
• Sub-sample approximately 30 mg of material for NMR analysis if necessary.
• Prepare an NMR sample in ca. 700 µL of CDCl3 in a 5 mm NMR tube.
13. NMR Analysis of the 100% Acetone Fraction
• Run a 1H spectrum of the sample on the 600 MHz instrument using the standard
Screen 1H parameter set. (Experiment time: ca. 4 min)
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Appendix B
Isoluffariellolide Spectra
1H NMR spectrum of isoluffariellolide (46) (600 MHz, CDCl3)
113
13C spectrum of isoluffariellolide (46) (150 MHz, CDCl3)
114
COSY spectrum of isoluffariellolide (46) (600 MHz, CDCl3)
115
Coupled HSQC spectrum of isoluffariellolide (46) (600 MHz, CDCl3)
116
HMBC spectrum of isoluffariellolide (46) (600 MHz, CDCl3)
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Appendix C
1-O-Methylisoluffariellolide Spectra
1H NMR spectrum of 1-O-methylisoluffariellolide (47) (600 MHz, CDCl3)
118
13C spectrum of 1-O-methylisoluffariellolide (47) (150 MHz, CDCl3)
119
COSY spectrum of 1-O-methylisoluffariellolide (47) (600 MHz, CDCl3)
120
Coupled HSQC spectrum of 1-O-methylisoluffariellolide (47) (600 MHz, CDCl3)
121
HMBC spectrum of 1-O-methylisoluffariellolide (47) (600 MHz, CDCl3)
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Appendix D
Secothorectolide Spectra
1H NMR spectrum of secothorectolide (49) (600 MHz, CDCl3)
123
13C spectrum of secothorectolide (49) (150 MHz, CDCl3)
124
COSY spectrum of secothorectolide (49) (600 MHz, CDCl3)
125
Coupled HSQC spectrum of secothorectolide (49) (600 MHz, CDCl3)
126
HMBC spectrum of secothorectolide (49) (600 MHz, CDCl3)
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Appendix E
Fistularin-3 Spectra
1H NMR spectrum of fistularin-3 (52) (600 MHz, CD3OD)
128
13C spectrum of fistularin-3 (52) (150MHz, CD3OD)
129
COSY spectrum of fistularin-3 (52) (600 MHz, CD3OD)
130
Coupled HSQC spectrum of fistularin-3 (52) (600 MHz, CD3OD)
131
HMBC spectrum of fistularin-3 (52) (600 MHz, CD3OD)
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Appendix F
Aeroplysinin-1 Spectra
1H NMR spectrum of aeroplysinin-1 (53) (600 MHz, CD3OD)
133
13C spectrum of aeroplysinin-1 (53) (150 MHz, CD3OD)
134
COSY spectrum of aeroplysinin-1 (53) (600 MHz, CD3OD)
135
Coupled HSQC spectrum of aeroplysinin-1 (53) (600 MHz, CD3OD)
136
HMBC spectrum of aeroplysinin-1 (53) (600 MHz, CD3OD)
137
Appendix G
LL-PAA216 Spectra
1H NMR spectrum of LL-PAA216 (54) (600 MHz, CD3OD)
138
13C spectrum of LL-PAA216 (54) (150 MHz, CD3OD)
139
COSY spectrum of LL-PAA216 (54) (600 MHz, CD3OD)
140
Coupled HSQC spectrum of LL-PAA216 (54) (600 MHz, CD3OD)
141
HMBC spectrum of LL-PAA216 (54) (600 MHz, CD3OD)
142
Appendix H
LL-PAA216 Spectra
1H NMR spectrum of LL-PAA216 (54) (600 MHz, d6-DMSO)
143
13C spectrum of LL-PAA216 (54) (150 MHz, d6-DMSO)
144
COSY spectrum of LL-PAA216 (54) (600 MHz, d6-DMSO)
145
Coupled HSQC spectrum of LL-PAA216 (54) (600 MHz, d6-DMSO)
146
HMBC spectrum of LL-PAA216 (54) (600 MHz, d6-DMSO)
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